<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Aging Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Aging Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Aging Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1663-4365</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31275138</article-id>
<article-id pub-id-type="pmc">6591269</article-id>
<article-id pub-id-type="doi">10.3389/fnagi.2019.00130</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ambrosini</surname>
<given-names>Yoko M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/702492/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Borcherding</surname>
<given-names>Dana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kanthasamy</surname>
<given-names>Anumantha</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/4972/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hyun Jung</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/306212/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Willette</surname>
<given-names>Auriel A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jergens</surname>
<given-names>Albert</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/438823/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Allenspach</surname>
<given-names>Karin</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/433033/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mochel</surname>
<given-names>Jonathan P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/432770/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University</institution>, <addr-line>Ames, IA</addr-line>, <country>United States</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Biomedical Engineering, University of Texas at Austin</institution>, <addr-line>Austin, TX</addr-line>, <country>United States</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Food Science and Human Nutrition, College of Agriculture and Life Sciences, Iowa State University</institution>, <addr-line>Ames, IA</addr-line>, <country>United States</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Veterinary Clinical Sciences, Iowa State University</institution>, <addr-line>Ames, IA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Jorge Busciglio, University of California, Irvine, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Julien Rossignol, Central Michigan University, United States; Michael Lardelli, University of Adelaide, Australia</p>
</fn>
<corresp id="c001">*Correspondence: Jonathan P. Mochel <email>jmochel@iastate.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>11</volume>
<elocation-id>130</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>5</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Ambrosini, Borcherding, Kanthasamy, Kim, Willette, Jergens, Allenspach and Mochel.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Ambrosini, Borcherding, Kanthasamy, Kim, Willette, Jergens, Allenspach and Mochel</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Identifying appropriate animal models is critical in developing translatable <italic>in vitro</italic> and <italic>in vivo</italic> systems for therapeutic drug development and investigating disease pathophysiology. These animal models should have direct biological and translational relevance to the underlying disease they are supposed to mimic. Aging dogs not only naturally develop a cognitive decline in many aspects including learning and memory deficits, but they also exhibit human-like individual variability in the aging process. Neurodegenerative processes that can be observed in both human and canine brains include the progressive accumulation of β-amyloid (Aβ) found as diffuse plaques in the prefrontal cortex (PFC), including the <italic>gyrus proreus (i.e., medial orbital PFC)</italic>, as well as the hippocampus and the cerebral vasculature. Tau pathology, a marker of neurodegeneration and dementia progression, was also found in canine hippocampal synapses. Various epidemiological data show that human patients with neurodegenerative diseases have concurrent intestinal lesions, and histopathological changes in the gastrointestinal (GI) tract occurs decades before neurodegenerative changes. Gut microbiome alterations have also been reported in many neurodegenerative diseases including Alzheimer’s (AD) and Parkinson’s diseases, as well as inflammatory central nervous system (CNS) diseases. Interestingly, the dog gut microbiome more closely resembles human gut microbiome in composition and functional overlap compared to rodent models. This article reviews the physiology of the gut-brain axis (GBA) and its involvement with neurodegenerative diseases in humans. Additionally, we outline the advantages and weaknesses of current <italic>in vitro</italic> and <italic>in vivo</italic> models and discuss future research directions investigating major human neurodegenerative diseases such as AD and Parkinson’s diseases using dogs.</p>
</abstract>
<kwd-group>
<kwd>gut-brain axis</kwd>
<kwd>neurodegenerative disease</kwd>
<kwd>canine</kwd>
<kwd>translational</kwd>
<kwd>animal models</kwd>
<kwd>review</kwd>
</kwd-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="155"></ref-count>
<page-count count="14"></page-count>
<word-count count="10932"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>The gut-brain axis (GBA) is a highly complex interactive network between the gut and the brain, composed of endocrinological, immunological and neural mediators, as summarized in <xref ref-type="fig" rid="F1">Figure 1</xref> (Rhee et al., <xref ref-type="bibr" rid="B114">2009</xref>). The GBA is largely mediated by the central nervous system (CNS), the enteric nervous system (ENS), and the intestinal microbiota (Grenham et al., <xref ref-type="bibr" rid="B49">2011</xref>). The extrinsic nerves of the gastrointestinal (GI) tract connect the gut to the brain through vagal and spinal afferent fibers, while the brain sends efferent sympathetic and parasympathetic fibers to the GI tract (Grenham et al., <xref ref-type="bibr" rid="B49">2011</xref>; Browning and Travagli, <xref ref-type="bibr" rid="B20">2014</xref>; Foster et al., <xref ref-type="bibr" rid="B38">2017</xref>). The hypothalamic pituitary adrenal (HPA)-axis is known as the main modulator of the physiological stress response but it also modulates alimentary function during digestion (Tsigos and Chrousos, <xref ref-type="bibr" rid="B144">2002</xref>) to facilitate gluconeogenesis. The hypothalamus releases corticotrophin-releasing factor (CRF) and different proteins within this family (e.g., CRF, urocortin 1–3) are also known to affect GI tract function, i.e., intestinal motility (Kihara et al., <xref ref-type="bibr" rid="B70">2001</xref>), permeability (Zheng et al., <xref ref-type="bibr" rid="B155">2013</xref>), and inflammation (Dinan et al., <xref ref-type="bibr" rid="B35">2006</xref>). Specifically, changes in the GI motility induced by urocortin administration were noted in conscious rats, and this study also suggested that the vagal pathway could regulate the central action of urocortin (Kihara et al., <xref ref-type="bibr" rid="B70">2001</xref>). Rats experiencing psychological stress showed decreased level of intestinal epithelial tight junction (TJ) proteins concurrent with increased intestinal permeability in the colon (Zheng et al., <xref ref-type="bibr" rid="B155">2013</xref>). In addition, among patients with irritable bowel syndrome (IBS), the levels of proinflammatory cytokines including interleukin (IL)-6 and IL-8 were elevated as a result of adrenocorticotropic hormone (ACTH) stimulation (i.e., cortisol release; Dinan et al., <xref ref-type="bibr" rid="B35">2006</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Molecular pathways involved in gut-brain axis (GBA). Suggested signaling pathways and cross-talk between the intestinal microbiota, the intestinal barrier, immune modulators, and neural (brain, vagus, and ENS) systems. The intestinal microbiota can affect the levels of circulating local cytokines, cause “leaky gut” with increase GI permeability, and ultimately affect brain function (Moloney et al., <xref ref-type="bibr" rid="B96">2014</xref>; Carabotti et al., <xref ref-type="bibr" rid="B22">2015</xref>). Intestinal bacterial metabolites such as SCFA, GABA, and serotonin precursors are neuroactive and can affect ENS and the brain (Grider and Piland, <xref ref-type="bibr" rid="B50">2007</xref>; Kimura et al., <xref ref-type="bibr" rid="B76">2011</xref>). Abbreviations: ENS, enteric nervous system; SCFAs, short-chain fatty acids; GABA, γ-aminobutyric acid; LPS, lipopolysaccharide; GI, gastrointestinal.</p>
</caption>
<graphic xlink:href="fnagi-11-00130-g0001"></graphic>
</fig>
<p>Various studies suggest that intestinal health has a significant impact on neurodegeneration despite the anatomical distance between the gut and the brain (Houser and Tansey, <xref ref-type="bibr" rid="B60">2017</xref>; Zhang et al., <xref ref-type="bibr" rid="B154">2018</xref>). Specifically, dysregulation of GBA cross-talk has been associated with metabolic syndrome (de Lartigue et al., <xref ref-type="bibr" rid="B82">2011</xref>; Grasset et al., <xref ref-type="bibr" rid="B48">2017</xref>) psychiatric disorders such as depression, anxiety, autism, as well as neurodegenerative diseases such as Parkinson’s disease (PD), and Alzheimer’s disease (AD; Sampson et al., <xref ref-type="bibr" rid="B121">2016</xref>; Zhang et al., <xref ref-type="bibr" rid="B154">2018</xref>). In reverse, these neurologic disorders are often times linked to altered intestinal health characterized by changes in the intestinal microbiota composition, which may disrupt the interplay between the gut and the brain (Esteve et al., <xref ref-type="bibr" rid="B36">2011</xref>; O’Mahony et al., <xref ref-type="bibr" rid="B103">2011</xref>). Many studies suggest that the intestinal microbiota contributes not only to modulating the communication and function of the GBA but also to modulating immune response through stimulation of cytokines and chemokines (Moloney et al., <xref ref-type="bibr" rid="B96">2014</xref>). Similarly, the GBA interacts with intestinal cells and the ENS, as well as the CNS through neuroendocrine and metabolic pathways (Carabotti et al., <xref ref-type="bibr" rid="B22">2015</xref>). Furthermore, ENS function can be influenced by the gut microbiota when they locally produce neurotransmitters, including γ-aminobutyric acid (GABA), amino-acid derivatives (e.g., serotonin, melatonin, and histamine) and fatty-acid derivatives (e.g., acetylcholine; Iyer et al., <xref ref-type="bibr" rid="B65">2004</xref>) or biologically active catecholamines (i.e., dopamine and norepinephrine) in the gut lumen (Asano et al., <xref ref-type="bibr" rid="B9">2012</xref>). The ENS is also targeted by bacterial metabolites such as short-chain fatty acids (SCFAs), including acetic acid, butyric acid, and propionic acid, which stimulate the sympathetic nervous system (Grider and Piland, <xref ref-type="bibr" rid="B50">2007</xref>; Kimura et al., <xref ref-type="bibr" rid="B76">2011</xref>), with downstream effects on learning and memory (Vecsey et al., <xref ref-type="bibr" rid="B146">2007</xref>; Stefanko et al., <xref ref-type="bibr" rid="B136">2009</xref>).</p>
</sec>
<sec id="s2">
<title>GBA in Neurodegenerative Diseases</title>
<p>Dysfunction of the GBA has been associated with psychiatric disorders including depression and anxiety, as well as neurodegenerative disorders including PD and AD (Sampson et al., <xref ref-type="bibr" rid="B121">2016</xref>; Jiang et al., <xref ref-type="bibr" rid="B68">2017</xref>). The following section will focus on recent findings of GBA involvement in PD and AD and their clinical features, as summarized in <xref ref-type="fig" rid="F2">Figure 2</xref>.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>The contrasts of clinical presentations on the GBA in health and neurodegenerative diseases. A stable intestinal microbiota is essential for healthy gut physiology and contributes to appropriate signaling along the GBA, promoting healthy physiologic status as well as central nervous system (CNS) status (<italic>left</italic>). Intestinal dysbiosis can negatively influence gut physiology and lead to abnormal GBA signaling (Friedland, <xref ref-type="bibr" rid="B39">2015</xref>), resulting in accumulation of misfolded amyloid species (Galloway et al., <xref ref-type="bibr" rid="B40">2007</xref>; de Lartigue et al., <xref ref-type="bibr" rid="B82">2011</xref>). This can ultimately alter CNS functions and anatomy (Wu et al., <xref ref-type="bibr" rid="B150">2017</xref>) as shown with magnetic resonance imaging (MRI) volumetric scans (<italic>upper middle</italic>). In the diseased CNS and gut state (<italic>right</italic>), cortical atrophy with the widening of the subarachnoid space (*), enlargement of the lateral ventricles (LV), hippocampus atrophy (HC), and brainstem (BS) volume reduction are seen with clinical and cognitive dysfunction (Johnson et al., <xref ref-type="bibr" rid="B69">2012</xref>; Lee et al., <xref ref-type="bibr" rid="B83">2015</xref>).</p>
</caption>
<graphic xlink:href="fnagi-11-00130-g0002"></graphic>
</fig>
<sec id="s2-1">
<title>Alzheimer’s Disease</title>
<p>AD is a progressive neurodegenerative disease characterized by senile plaques consisting of misfolded β-amyloid (Aβ) fibrils and oligomers (Iadanza et al., <xref ref-type="bibr" rid="B62">2018</xref>), as well as hyperphosphorylated tau protein in the various regions of the brain including cerebral cortex, locus coeruleus, and hippocampus (Llorens et al., <xref ref-type="bibr" rid="B89">2017</xref>). Although such protein aggregation in the brain as well as non-neural tissues (i.e., the blood vessels, skin, subcutaneous tissue, and intestine) is a histological feature of AD, such deposition could simply be a consequence of various (epi) genetic alterations triggered by environmental exposures such as sociological, or medical nutritional stress (Lemche, <xref ref-type="bibr" rid="B85">2018</xref>). In fact, synthetic Aß42 peptide aggregation has been reported in <italic>Caenorhabditis elegans</italic> aging models (Patel et al., <xref ref-type="bibr" rid="B106">2017</xref>). Aβ fibrillar accumulation can coincide with clinical signs of cognitive dysfunction (Attems et al., <xref ref-type="bibr" rid="B11">2005</xref>; Herzig et al., <xref ref-type="bibr" rid="B56">2006</xref>; Pistollato et al., <xref ref-type="bibr" rid="B110">2016</xref>), however, it is noteworthy that there is a high degree of variation in the extent of Aβ accumulation among patients with cognitive decline (Monsell et al., <xref ref-type="bibr" rid="B97">2015</xref>). Although almost 100 years have passed since the very first diagnosis of AD, the exact pathogenesis of the disease is still largely unknown (Iadanza et al., <xref ref-type="bibr" rid="B62">2018</xref>). Likewise, no effective therapy for modulation of AD is currently available.</p>
<p>One hypothesis for the involvement of the GBA in the pathophysiology of neurodegenerative diseases is microbial dysbiosis, which occurs as a result of antibiotic exposure (Vangay et al., <xref ref-type="bibr" rid="B145">2015</xref>), dietary changes (Muegge et al., <xref ref-type="bibr" rid="B100">2011</xref>), probiotics (Delzenne et al., <xref ref-type="bibr" rid="B34">2011</xref>), or a variety of other disease conditions (Tilg and Moschen, <xref ref-type="bibr" rid="B143">2014</xref>; Rosenfeld, <xref ref-type="bibr" rid="B117">2015</xref>). Specifically, various studies have shown an association between gut microbiome dysbiosis and the aggregation of Aβ peptides in intestinal epithelial cells (Galloway et al., <xref ref-type="bibr" rid="B40">2007</xref>, <xref ref-type="bibr" rid="B41">2009</xref>) and the CNS (Nam et al., <xref ref-type="bibr" rid="B101">2017</xref>; Lin et al., <xref ref-type="bibr" rid="B87">2016</xref>) after high-fat diet feeding. Different components of the microbiota, such as bacteria, can excrete an immunogenic mixture of functional lipopolysaccharides (LPS), amyloid species, and exudates from their outer membranes into the local intestinal environment (Oli et al., <xref ref-type="bibr" rid="B104">2012</xref>; Schwartz and Boles, <xref ref-type="bibr" rid="B128">2013</xref>). Amyloid species and LPS are usually soluble, although they can polymerize and form insoluble fibrous protein aggregates, leading to stimulation of oxidative stress and cross-seeding of further protein aggregation (Morales et al., <xref ref-type="bibr" rid="B99">2013</xref>; Friedland, <xref ref-type="bibr" rid="B39">2015</xref>; Iadanza et al., <xref ref-type="bibr" rid="B62">2018</xref>). For example, the endotoxin from <italic>Escherichia coli</italic> was shown to enhance the Aβ fibril formation in an <italic>in vitro</italic> model (Asti and Gioglio, <xref ref-type="bibr" rid="B10">2014</xref>). Also, co-incubation of Aβ peptide with LPS was shown to potentiate amyloids fibrillogenesis (Asti and Gioglio, <xref ref-type="bibr" rid="B10">2014</xref>), and systemic injection of LPS in a transgenic AD mouse model resulted in severe amyloid deposition and tau pathology (Aziz et al., <xref ref-type="bibr" rid="B14">2013</xref>; Mitew et al., <xref ref-type="bibr" rid="B93">2013</xref>; Paula-Lima et al., <xref ref-type="bibr" rid="B108">2013</xref>; Saulnier et al., <xref ref-type="bibr" rid="B124">2013</xref>). Moreover, recent studies suggest that the structural overlap between bacterial amyloid proteins to human Aβ could induce <italic>molecular mimicry</italic>, an immune response against the self-antigens stimulated by a foreign antigen sharing structural similarities, and ultimately causing greater inflammatory responses to cerebral Aβ due to altered gut microbiota (Delzenne et al., <xref ref-type="bibr" rid="B34">2011</xref>; Muegge et al., <xref ref-type="bibr" rid="B100">2011</xref>; Rosenfeld, <xref ref-type="bibr" rid="B117">2015</xref>).</p>
<p>Another hypothesis for the pathogenesis of misfolded protein aggregation is the “Prion Concept.” This hypothesis states that many neurodegenerative diseases exhibit accumulation of fibrillary, misfolded proteins similar to the propagation of prionopathies in the CNS (Goedert, <xref ref-type="bibr" rid="B44">2015</xref>). Prionopathy also involves the GBA and the local immune system, where prions accumulate in dendritic cells in the Peyer’s patches and other lymphoid follicles once entering the intestinal epithelium layer (Ano et al., <xref ref-type="bibr" rid="B8">2009</xref>). Interestingly, earlier studies in a senescence-accelerated mouse model identified systemic senile amyloid proteins in Peyer’s patches (Yoshioka et al., <xref ref-type="bibr" rid="B151">1990</xref>). By interacting with dendritic cells, the misfolded protein might be transported to the ENS, and ultimately spread to the CNS compartment (Ano et al., <xref ref-type="bibr" rid="B8">2009</xref>). A significant amount of functional amyloid protein was shown to be generated by certain bacteria, such as <italic>E. coli</italic>, <italic>Bacillus subtilis</italic>, <italic>Salmonella enterica</italic>, <italic>Salmonella typhimurium</italic>, and <italic>Staphylococcus aureus</italic>, and may contribute to the pathology of AD through the accumulation of misfolded Aβ oligomers and fibrils (Hufnagel et al., <xref ref-type="bibr" rid="B61">2013</xref>; Schwartz and Boles, <xref ref-type="bibr" rid="B128">2013</xref>). Some bacterial species, such as <italic>Lactobacillus</italic> spp. and <italic>Bifidobacterium</italic> spp. (both gram-positive bacteria) are known to possess the ability to metabolize glutamate, a well-known primary excitatory neurotransmitter, to produce GABA, a well-known primary inhibitory neurotransmitter (Paula-Lima et al., <xref ref-type="bibr" rid="B108">2013</xref>). These observations suggest that alteration of the gut microbiota can compromise the endogenous production of GABA (Saulnier et al., <xref ref-type="bibr" rid="B124">2013</xref>). In turn, alteration of GABA signaling in the brain has been linked to cognitive impairment, AD, anxiety, and depression (Aziz et al., <xref ref-type="bibr" rid="B14">2013</xref>; Hornig, <xref ref-type="bibr" rid="B59">2013</xref>; Mitew et al., <xref ref-type="bibr" rid="B93">2013</xref>; Paula-Lima et al., <xref ref-type="bibr" rid="B108">2013</xref>). Alternatively, gut bacteria can affect peripheral nerve functions through the production of neuromodulatory metabolites such as short-chain fatty acid (SCFAs; Kimura et al., <xref ref-type="bibr" rid="B76">2011</xref>). SCFAs, i.e., acetic acid, butyric acid, and propionic acid, are produced by bacterial fermentation of dietary fiber in the colon (Kimura et al., <xref ref-type="bibr" rid="B76">2011</xref>). SCFAs can stimulate the sympathetic nervous system to release serotonin, ultimately influencing the CNS cognitive processes such as learning and memory (Grider and Piland, <xref ref-type="bibr" rid="B50">2007</xref>). Catabolism of SCFAs to ketone bodies may also provide an alternative source of ATP to the brain, which could be beneficial given that progressive glucose dysmetabolism has been reported in patients with AD (Sokoloff, <xref ref-type="bibr" rid="B135">1973</xref>). Importantly, lower levels of SCFAs have also been shown to negatively affect immune responses, epithelial cell growth, and possibly affect the function of both the central and peripheral nervous systems (Kimura et al., <xref ref-type="bibr" rid="B76">2011</xref>; Bienenstock et al., <xref ref-type="bibr" rid="B15">2015</xref>).</p>
</sec>
<sec id="s2-2">
<title>Parkinson’s Disease</title>
<p>Patients with PD present with classic motor symptoms, such as asymmetric resting tremor, that are caused by progressive dopaminergic neuronal death in the substantia nigra pars compacta and loss of dopaminergic signaling (Houser and Tansey, <xref ref-type="bibr" rid="B60">2017</xref>). The pathophysiology of neurodegeneration in PD has not been established. However, abundant evidence suggests that neuroinflammation and glial cell activation could play a significant role in PD etiopathogenesis (Rocha et al., <xref ref-type="bibr" rid="B115">2015</xref>). Proinflammatory signaling molecules, including cytokines (i.e., IL-1β, IL-6, and TNF-α; Mogi et al., <xref ref-type="bibr" rid="B95">1996</xref>) or enzymes [i.e., nitric oxide synthase (NOS) and cyclooxygenase-2 (COX-2); Prigione et al., <xref ref-type="bibr" rid="B111">2009</xref>], and oxidative stress are considered major contributing factors to neurodegeneration and cell death in PD.</p>
<p>One of the leading hypotheses for the pathogenesis of PD is the abnormal accumulation of α-synuclein (αSYN; Wong and Krainc, <xref ref-type="bibr" rid="B149">2017</xref>). This protein is present in various cell types in the body, and PD patients show increased expression of αSYN at presynaptic terminals of neurons and neurite projections (Wong and Krainc, <xref ref-type="bibr" rid="B149">2017</xref>). This protein is highly soluble and regulates the presynaptic release of important neurotransmitters such as dopamine (Wong and Krainc, <xref ref-type="bibr" rid="B149">2017</xref>). The αSYN protein is also expressed within the ENS and can be detected in intestinal submucosal neuronal structures from neurologically healthy individuals (Böttner et al., <xref ref-type="bibr" rid="B17">2012</xref>; Shannon et al., <xref ref-type="bibr" rid="B130">2012</xref>; Gold et al., <xref ref-type="bibr" rid="B45">2013</xref>). However, through interactions with environmental factors and other proteins and small molecules (Hasegawa et al., <xref ref-type="bibr" rid="B54">2002</xref>; Breydo et al., <xref ref-type="bibr" rid="B19">2012</xref>), αSYN follows a β-sheet structure formation and loses its physiologic membrane-binding capacity, leading to the aggregation of misfolded proteins forming so-called Lewy neurites and Lewy bodies in dopaminergic neurons of substantia nigra and noradrenergic neurons of the locus coeruleus (Hasegawa et al., <xref ref-type="bibr" rid="B54">2002</xref>). Aggregates of misfolded αSYN proteins decrease mitochondrial complex I activity, thus reducing the physiologic functions of mitochondria, which ultimately leads to oxidative stress in the neuron (Jenner, <xref ref-type="bibr" rid="B67">2003</xref>; Prigione et al., <xref ref-type="bibr" rid="B111">2009</xref>). Individuals with mutations in the αSYN gene <italic>SNCA</italic> or duplication of the wild-type <italic>SNCA</italic> allele are known to develop early-onset, rapidly-progressive PD (Klein and Westenberger, <xref ref-type="bibr" rid="B78">2012</xref>). The spread of αSYN proteins from the ENS to the CNS by transsynaptic cell-to-cell transmission in both sympathetic and parasympathetic nervous systems (Danzer et al., <xref ref-type="bibr" rid="B31">2012</xref>) is the foundation for the “Prion Concept” in PD pathophysiology (Brundin et al., <xref ref-type="bibr" rid="B21">2016</xref>). Multiple studies have demonstrated the presence of αSYN aggregates in intestinal biopsies from clinically normal individuals who would develop PD later in their lives (Braak et al., <xref ref-type="bibr" rid="B18">2006</xref>; Shannon et al., <xref ref-type="bibr" rid="B130">2012</xref>; Hilton et al., <xref ref-type="bibr" rid="B57">2014</xref>). This finding indicates that intestinal αSYN precedes sufficient CNS neurodegeneration to produce motor dysfunctions (Houser and Tansey, <xref ref-type="bibr" rid="B60">2017</xref>). Various clinical GI signs or the characteristic PD ENS pathology often occur before brain functions are actually affected, with constipation being the most common GI complaint in PD (Sakakibara et al., <xref ref-type="bibr" rid="B120">2003</xref>). This is likely due to an increased intestinal transit time both in the small and large intestines of PD patients (Sakakibara et al., <xref ref-type="bibr" rid="B120">2003</xref>). In fact, it has been shown that constipation can be a pre-motor symptom of PD years before the patients present with the clinical signs consistent with CNS degeneration (Gao et al., <xref ref-type="bibr" rid="B42">2011</xref>; Lesser, <xref ref-type="bibr" rid="B86">2002</xref>). In addition, an increased intestinal permeability was shown in PD patients compared to healthy controls (Schwiertz et al., <xref ref-type="bibr" rid="B129">2018</xref>). Other studies suggest that there is an increased risk of developing dementia (Chen et al., <xref ref-type="bibr" rid="B25">2016</xref>) or PD (Lai et al., <xref ref-type="bibr" rid="B81">2014</xref>) in patients with IBS.</p>
<p>Similar to the trend in AD research, the relationships between the intestinal microbiota and PD pathophysiology and their association with disturbed GI motility have been studied extensively and some of the reported differences include a decrease in fecal numbers of <italic>Prevotella</italic> spp. and <italic>Clostridium</italic> spp. in PD patients (Tan et al., <xref ref-type="bibr" rid="B141">2014</xref>; Scheperjans et al., <xref ref-type="bibr" rid="B125">2015</xref>). These intestinal bacteria are a major source of SCFAs, particularly butyrate, folate (vitamin B9), and thiamine (vitamin B1), which are critical for the long-term maintenance of the epithelial barrier function (Tan et al., <xref ref-type="bibr" rid="B141">2014</xref>; Scheperjans et al., <xref ref-type="bibr" rid="B125">2015</xref>). Interestingly, chronic exposure to these SCFAs has been associated with clinical improvement in patients with PD [i.e., decreased dopaminergic degeneration and disruption of blood-brain barrier (BBB)] and clinical symptoms (Luong and Nguyen, <xref ref-type="bibr" rid="B90">2013</xref>; Scheperjans et al., <xref ref-type="bibr" rid="B125">2015</xref>; Liu et al., <xref ref-type="bibr" rid="B88">2017</xref>), possibly due to ketogenesis. Finally, there are a few anecdotal reports suggesting a role for the Tobacco Mosaic virus (TMV; Friedland, <xref ref-type="bibr" rid="B39">2015</xref>) in the pathophysiology of PD, but these preliminary findings need to be consolidated by additional studies on the topic.</p>
</sec>
</sec>
<sec id="s3">
<title>Experimental Approaches to Investigating the GBA</title>
<p>Both static and dynamic <italic>in vitro</italic> models have been utilized to advance the understanding of the role of the GBA in neurodegenerative diseases. In addition, novel primary intestinal stem cell (ISC) culture systems have been utilized to mimic both physiologic and pathophysiologic intestinal conditions <italic>in vitro</italic> contributing to defining gut-cross talk with local environment (Gonzalez et al., <xref ref-type="bibr" rid="B46">2013</xref>; Sato and Clevers, <xref ref-type="bibr" rid="B123">2013</xref>; Chandra et al., <xref ref-type="bibr" rid="B23">2018</xref>). The benefits and disadvantages of two current <italic>in vitro</italic> models are summarized in <xref ref-type="fig" rid="F3">Figure 3</xref>. Importantly, cognitive dysfunction is highly prevalent not only in AD patients but also in approximately one-third of patients with PD (herein referred to as “non-motor symptom” of PD; Chaudhuri et al., <xref ref-type="bibr" rid="B24">2006</xref>). In the “<italic>In Vitro</italic> Models” section and “<italic>In Vivo</italic> Animal Models” section, our main focus will be on AD. However, findings from these <italic>in vivo</italic> models for investigating mechanisms of cognitive impairment would be relevant to PD as well. The similarities and differences of clinical and histological observations in humans, dogs, and rodents are further summarized in <xref ref-type="fig" rid="F4">Figure 4</xref>.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Schematic of organoid 3D culture development and integration into Transwell and Microfluidic systems. First, the intestinal biopsy is obtained <italic>via</italic> endoscopically or surgically, then villi and crypts are isolated with intestinal stem cells (ISCs) and Paneth-like cells. When cultured in an extracellular matrix with appropriate microenvironment factors, long-term culture of 3D canine enteroids/colonoids (ENT/COL) is accomplished. Second, a single cell suspension from such 3D culture system will be integrated with Transwell (left) and microfluidic (right) systems. On the transwell insert, 3D ENT/COL is cultured on top of the porous membrane with culture medium in the apical (blue) side and then submerged in culture medium in the basolateral (red) wells. A schematic of a Gut-on-a-chip (GOAC) microdevice allows a closed system with microtubing. Arrows indicate the direction of the flow of culture medium in the apical (blue) and basolateral (red) microchannels.</p>
</caption>
<graphic xlink:href="fnagi-11-00130-g0003"></graphic>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Comparative features of neurodegenerative changes and anatomy in different mammalian species. Similarities and differences in the development of neurodegenerative diseases, such as Alzheimer’s disease (AD), in human, dog, and mouse are listed.</p>
</caption>
<graphic xlink:href="fnagi-11-00130-g0004"></graphic>
</fig>
<sec id="s3-1">
<title><italic>In vitro</italic> Models</title>
<sec id="s3-1-1">
<title>Static Systems</title>
<p>Development of translatable <italic>in vitro</italic> models is critical for elucidating disease pathophysiology and developing effective therapies for neurodegenerative diseases. Currently, only about 7% of investigational compounds tested in phase III clinical trials progress on to the market in neurology (Kola and Landis, <xref ref-type="bibr" rid="B80">2004</xref>). This is worse than the average of 11% success rate of drugs marketed for all disease categories (Kola and Landis, <xref ref-type="bibr" rid="B80">2004</xref>; Adjei et al., <xref ref-type="bibr" rid="B1">2009</xref>). The BBB, a unique interface between the peripheral vascular system and the CNS, is a unique feature of the GBA (Rubin et al., <xref ref-type="bibr" rid="B119">1991</xref>). The critical roles of BBB include supplying nutrients to the CNS, allowing the removal of waste products (such as urea or potassium), and preventing blood-borne pathogens and toxic products from entering into the brain (Alcendor et al., <xref ref-type="bibr" rid="B3">2012</xref>). The BBB consists of TJs between capillary endothelial cells without fenestrations, and therefore allows the BBB to maintain a low level of pinocytosis, which preserves the structural integrity of BBB (Alcendor et al., <xref ref-type="bibr" rid="B4">2013</xref>).</p>
<p>Attempts to develop an <italic>in vitro</italic> model to recapitulate the complexity of the BBB have included brain microvascular endothelial cells and astrocytes in a Transwell culture (<xref ref-type="bibr" rid="B2">Ahmed et al., in press</xref>). Leveraging its similarity with conventional 2-dimensional (2D) culture systems and its relative simplicity, the Transwell BBB system has been widely used in a research setting (Rubin et al., <xref ref-type="bibr" rid="B119">1991</xref>). However, the maintenance of TJ function requires the application of the shear forces which traditional static Transwell systems are not able to offer (Santaguida et al., <xref ref-type="bibr" rid="B122">2006</xref>). These critical shortcomings, including lower transepithelial electrical resistance (TEER) and higher endothelial permeability than reported <italic>in vivo</italic>, typically lead to an overestimation of drug permeability across the BBB (Santaguida et al., <xref ref-type="bibr" rid="B122">2006</xref>).</p>
<p>Additionally, current <italic>in vitro</italic> models does not replicate the close physiological cross-talk between pericytes and the capillary endothelium that comprise the neurovascular unit (Jamieson et al., <xref ref-type="bibr" rid="B66">2017</xref>). Successful integration of intraluminal flow for the <italic>in vitro</italic> culture of astrocytes has resulted in more physiological endothelial cell polarity and strengthening of TJs (Cucullo et al., <xref ref-type="bibr" rid="B29">2011</xref>).</p>
<p>Attempts were made to study the GBA using a Transwell culture system as well (Haller et al., <xref ref-type="bibr" rid="B52">2000</xref>). However, this system included only a few components of the GBA, and it is important to note that Caco-2 cells, an immortalized cell line derived from human colorectal adenocarcinoma, are used to model the enteric epithelial cells in this system. Given these collective limitations, as well as the lack of integration of microbiome/ENS in the <italic>in vitro</italic> system, the results derived from these studies may not be readily indicative of translational efficacy.</p>
<p>Importantly, our group recently established canine primary enteroid and colonoid (ENT/COL) culture systems (Kingsbury et al., <xref ref-type="bibr" rid="B77">2017</xref>; Mochel et al., <xref ref-type="bibr" rid="B94">2017</xref>). This is a canine ISC culture system which closely mimics the physiologic structure and function of <italic>in vivo</italic> intestines from both healthy and diseased individuals (Chandra et al., <xref ref-type="bibr" rid="B23">2018</xref>), and allows for the investigation of pathophysiology and treatment effects. Of note, canine cognitive dysfunction (CCD) is a well-studied clinical analog of AD (Kol et al., <xref ref-type="bibr" rid="B79">2015</xref>; Schütt et al., <xref ref-type="bibr" rid="B126">2015</xref>; Hoffman et al., <xref ref-type="bibr" rid="B58">2018</xref>; Wang et al., <xref ref-type="bibr" rid="B147">2018</xref>). Since dogs and humans share an anatomically and physiologically very similar GI tract and harbor a taxonomically and functionally largely overlapping microbiome, the dog provides unique features as a spontaneous model of disease (Coelho et al., <xref ref-type="bibr" rid="B27">2018</xref>; Alessandri et al., <xref ref-type="bibr" rid="B5">2019</xref>). Overall, this canine model may hold promise with its translational relevance for exploration of avenues of novel therapeutics for neurologic disease in the near future (Mochel et al., <xref ref-type="bibr" rid="B94">2017</xref>).</p>
</sec>
<sec id="s3-1-2">
<title>Dynamic Model Systems Using Microfluidics</title>
<p>Only recently, a novel <italic>ex vivo</italic> model offering dynamic shear forces to mimic physiologic conditions called organ-on-a-chip (organ-OAC) has emerged (Kimura et al., <xref ref-type="bibr" rid="B75">2008</xref>; Sung et al., <xref ref-type="bibr" rid="B140">2011</xref>). This microfluidic device contains microtubing that allows for continuous flow of media and is comprised of multiple cell culture channels enabling co-culture of different cell types (Kim and Ingber, <xref ref-type="bibr" rid="B71">2013</xref>; Kim et al., <xref ref-type="bibr" rid="B73">2016a</xref>). Specifically, the Gut-on-a-chip (GOAC) models the complex human intestinal anatomy into a two-microchannel device where volumetric flow rate, mechanical deformations, and fluid shear stress can be adjusted to reproduce the <italic>in vivo</italic> physiology of the gut (Kim and Ingber, <xref ref-type="bibr" rid="B71">2013</xref>; Kim et al., <xref ref-type="bibr" rid="B73">2016a</xref>). This biomimetic approach allows for the growth of the villous microarchitecture in Caco-2 cells, while proliferative cells from the intestinal crypt spontaneously migrate toward the villous tip similar to intestinal cells <italic>in vivo</italic> (Kim and Ingber, <xref ref-type="bibr" rid="B71">2013</xref>). Also, differentiation of intestinal epithelial cell lines into four lineage-dependent subtypes (absorptive, mucus-secretory, enteroendocrine, and Paneth) is observed in this microfluidic system and presents a clear advantage over traditional 2D static culture systems (Kim and Ingber, <xref ref-type="bibr" rid="B71">2013</xref>). When Caco-2 cells form 3-dimensional (3D) villi in the GOAC, they typically show enhanced epithelial barrier integrity, increased mucus production, and elevated drug-metabolizing P450 activity with augmented surface area and glucose reuptake, which are all relevant factors for modeling human intestinal physiology (Kim and Ingber, <xref ref-type="bibr" rid="B71">2013</xref>). The 3D microarchitecture and increased mucus production are beneficial to grow live bacteria comprising the human gut microbiota using controlled flow and shear forces mimicking intestinal peristalsis (Kim et al., <xref ref-type="bibr" rid="B72">2012</xref>; Kim et al., <xref ref-type="bibr" rid="B73">2016a</xref>; Shin and Kim, <xref ref-type="bibr" rid="B133">2018</xref>). Steady-state culture conditions inside the microchannels prevent the depletion of nutrients and the overgrowth of microbes (Kim et al., <xref ref-type="bibr" rid="B72">2012</xref>). Critically, overgrowth of bacteria was seen only when manipulation to the shear stress was applied in the GOAC, which emulates the pathophysiological feature of the ileus (Kim et al., <xref ref-type="bibr" rid="B73">2016a</xref>). By leveraging the innovative features of the GOAC, studies on the complex interactions between the host intestinal epithelium and the gut microbiome were also made possible (Kim et al., <xref ref-type="bibr" rid="B72">2012</xref>; Kim et al., <xref ref-type="bibr" rid="B74">2016b</xref>; Shin and Kim, <xref ref-type="bibr" rid="B133">2018</xref>). For example, interactions between the intestinal epithelium, immune cell components, and intestinal bacteria (including non-pathogenic, pathogenic, or probiotic strains) were characterized by adding individual components one-at-a-time in a spatiotemporal manner (Kim et al., <xref ref-type="bibr" rid="B73">2016a</xref>; Shin and Kim, <xref ref-type="bibr" rid="B133">2018</xref>). This approach will enable researchers to evaluate the role of gut microbiome-brain axis in the development and progression of numerous intestinal diseases, such as inflammatory bowel disease (IBD) or colorectal cancer (CRC). Furthermore, the anoxic-oxic interface (AOI) of the oxygen gradient inside a modified GOAC was successfully recreated in a recent report, allowing for the co-culture of strict anaerobic intestinal bacteria and members of the fecal microbiome (Shin et al., <xref ref-type="bibr" rid="B132">2019</xref>). This technology can be used to investigate the cross-talk between the gut microbiome and probiotics on intestinal health.</p>
<p>Recently, a BBB-OAC was established and showed physiological barrier functions (Wang et al., <xref ref-type="bibr" rid="B148">2017</xref>), using ENS and enteroendocrine cells (EEC)-OAC combined to assess the GBA microenvironment (<xref ref-type="bibr" rid="B2">Ahmed et al., in press</xref>). Advancement in bioengineering techniques will allow incorporating multiple compartments in one <italic>in vitro</italic> system such as a GBA-OAC (Choe et al., <xref ref-type="bibr" rid="B26">2017</xref>; <xref ref-type="bibr" rid="B2">Ahmed et al., in press</xref>; Lee and Sung, <xref ref-type="bibr" rid="B84">2018</xref>). Despite the great promise of the Organ Chip technology, the transfer of cells from a macroscopic environment (e.g., well-plates) to a microfluidic system requires significant revision and optimization of cell culture protocols. Multiple factors differentiate microfluidic from macroscopic cell cultures. Microfluidic systems, for instance, harbor different culture channel surfaces and require fewer media volume as compared with macroscopic cultures (Sung and Shuler, <xref ref-type="bibr" rid="B139">2009</xref>). Despite these limiting factors including the technology being labor-intensive, GOACs are a fast-growing model system that holds greater potential to investigate primary GI diseases. By extension, this system may be able to model GBA microenvironment and brain associations to better understand the role of enteric dysbiosis and neurodegenerative diseases.</p>
</sec>
</sec>
<sec id="s3-2">
<title><italic>In vivo</italic> Animal Models</title>
<p>While transgenic rodent models have been utilized to address targeted mechanistic questions relating to neuropathology and altered behavior (Hall and Roberson, <xref ref-type="bibr" rid="B51">2012</xref>, 201), it is important to realize the inherent limitations of these <italic>in vivo</italic> models. Since mouse studies are used in the initial stages of drug discovery, the limitations in this animal model likely contribute to the poor success rate of AD drug discovery over the last 10 years (Kola and Landis, <xref ref-type="bibr" rid="B80">2004</xref>; Adjei et al., <xref ref-type="bibr" rid="B1">2009</xref>). One major limitation in studying the human GBA is a lack of an accurate animal model system that successfully replicates human ENS-microbiome interactions in health and disease. Investigation into the role of GBA with therapeutic interventions may require animal studies with tissues derived from animals that develop naturally occurring disease, including the dog. Since rodent diets differ substantially from that of humans, and diets are an important environmental factor shaping composition of the microbiome, comparing the effect of diet between species that harbor different microbial compositions (and likely functions) is difficult (Flint, <xref ref-type="bibr" rid="B37">2011</xref>; Ravussin et al., <xref ref-type="bibr" rid="B113">2012</xref>). For example, mice preferentially consume grains and cereals which contain relatively low ascorbic acid but have evolved their ability to synthesize this essential cofactor while humans have lost the ability to do so (Perlman, <xref ref-type="bibr" rid="B109">2016</xref>) since they are omnivores. Different cytochrome P450 enzymes exist in mice compared to those in humans, thus each species has unique xenobiotic metabolism pathways that contribute to detoxification in each species (Martignoni et al., <xref ref-type="bibr" rid="B91">2006</xref>; Anderson et al., <xref ref-type="bibr" rid="B7">2009</xref>). These differing means of detoxification may be another reason why toxicology testing in mice has poor translatability to human toxicity (Olson et al., <xref ref-type="bibr" rid="B105">2000</xref>).</p>
<p>Another factor explaining why rodent models do not mirror aspects of human pathophysiology is related to the limited tendency of some of these induced models to develop amyloidosis. As discussed before, AD is histologically characterized by the presence of Aβ aggregates in the walls of cerebral vessels (Attems, <xref ref-type="bibr" rid="B12">2005</xref>; Herzig et al., <xref ref-type="bibr" rid="B56">2006</xref>). Rodent models do not produce human sequence Aβ naturally (Shepherd et al., <xref ref-type="bibr" rid="B131">2018</xref>), which limits their investigative utility as a translational model. Transgenic mouse models overexpressing mutant human amyloid precursor protein (APP) alone, or combined with transgenic presenilin 1 (PS1) and presenilin 2 (PS2), do have secondary Aβ plaque formation in the brain, histologically mimicking AD (Götz et al., <xref ref-type="bibr" rid="B47">2008</xref>). However, these transgenic mouse models naturally have molecular and systemic resistance to Aβ pathology and therefore do not develop the extensive neuronal loss and clinical signs seen in human AD patients (Martin et al., <xref ref-type="bibr" rid="B92">2011</xref>). Lastly, there are fundamental differences in the anatomic folding of the cerebral cortex, with humans having a gyrencephalic brain and rodents having a lissencephalic brain (Sun and Hevner, <xref ref-type="bibr" rid="B138">2014</xref>). A recent meta-analysis study demonstrates that various transgenic mouse models of AD show different characteristics compared to what have observed in the human AD (Hargis and Blalock, <xref ref-type="bibr" rid="B53">2017</xref>). Specifically, the findings from spontaneous AD people were not consistent with those in transgenic AD mouse models, while human studies hold similar findings across different studies (Hargis and Blalock, <xref ref-type="bibr" rid="B53">2017</xref>). The study also found that among the major transgenic AD mouse the findings were not similar to one another (Hargis and Blalock, <xref ref-type="bibr" rid="B53">2017</xref>).</p>
<p>Accumulated data shows that the dog provides a superior model system to transgenic mouse models for investigating the influence of aging in the development and treatment of neurologic disease (Head, <xref ref-type="bibr" rid="B55">2013</xref>). The dog is a more translationally relevant species because of the environmental, genomic, and intestinal physiologic features they share with humans (Cummings et al., <xref ref-type="bibr" rid="B30">1996</xref>). Dogs are an ideal aging model since they show a parallel aging process to humans as evidenced by beagles between 5 and 9 years old showing cognitive dysfunction similar to humans between 40 and 60 years old (Patronek et al., <xref ref-type="bibr" rid="B107">1997</xref>). In addition, brain vs. body size compares favorably between humans and dogs as compared with mice (Roth and Dicke, <xref ref-type="bibr" rid="B118">2005</xref>), which is another advantage of using the dog as a disease animal model for neurologic diseases as canine brains undergo similar stress as humans (Roth and Dicke, <xref ref-type="bibr" rid="B118">2005</xref>). Canine spontaneous disease models also offer additional predictive value for treatment efficacy before transitioning to human clinical trials (Kol et al., <xref ref-type="bibr" rid="B79">2015</xref>; Schütt et al., <xref ref-type="bibr" rid="B127">2016</xref>). Finally, dog genes have adapted to a starch-rich diet during domestication similar to humans, which suggests that studying such adaptations may improve our understanding of human evolution and disease (Axelsson et al., <xref ref-type="bibr" rid="B13">2013</xref>).</p>
</sec>
<sec id="s3-3">
<title>Canine Models as Natural Models for Neurodegenerative Diseases: Similarities and Differences</title>
<p>Many human chronic disorders with a mixed genetic-environmental etiology (e.g., Diabetes Mellitus, IBD, CRC), including AD and PD, have well-studied clinical analogs in dogs (Kol et al., <xref ref-type="bibr" rid="B79">2015</xref>; Schütt et al., <xref ref-type="bibr" rid="B127">2016</xref>; Hoffman et al., <xref ref-type="bibr" rid="B58">2018</xref>). Particularly relevant to AD, aged dogs with CCD spontaneously develop a progressive decline in cognitive function associated with advanced imaging abnormalities and histopathological features similar to AD (Davis and Head, <xref ref-type="bibr" rid="B32">2014</xref>). For example, CCD dogs display progressive AD-like cortical atrophy (Rofina et al., <xref ref-type="bibr" rid="B116">2006</xref>; Pugliese et al., <xref ref-type="bibr" rid="B112">2010</xref>) in areas of the hippocampus that may be accompanied by ventricular enlargement (Su et al., <xref ref-type="bibr" rid="B137">2005</xref>). Further, aged dog brains show other neuropathological and degenerative features similar to AD, including diffuse Aβ plaque deposition (Cummings et al., <xref ref-type="bibr" rid="B30">1996</xref>; Borràs et al., <xref ref-type="bibr" rid="B16">1999</xref>) with cortical amyloid angiopathy (CAA; Ishihara et al., <xref ref-type="bibr" rid="B64">1991</xref>), neuronal loss in temporal regions first affected by AD (Colle et al., <xref ref-type="bibr" rid="B28">2000</xref>), and dysfunction of neurotransmitter systems (Insua et al., <xref ref-type="bibr" rid="B63">2012</xref>). Other neuropathological abnormalities shared between dogs and humans include hyperphosphorylated tau proteins in the brain (Yu et al., <xref ref-type="bibr" rid="B152">2011</xref>; Böttner et al., <xref ref-type="bibr" rid="B17">2012</xref>; Smolek et al., <xref ref-type="bibr" rid="B134">2016</xref>) and increased plasma Aβ<sub>1–42</sub> levels, one of the biomarkers of AD (Schütt et al., <xref ref-type="bibr" rid="B126">2015</xref>).</p>
<p>In addition to CCD as a model for AD, certain dog breeds are considered spontaneous models for PD. Canine multiple system degeneration (CMSD) is a fatal, inheritable movement disorder first described in Kerry Blue Terriers (deLahunta and Averill, <xref ref-type="bibr" rid="B33">1976</xref>), then in Chinese Crested dogs (O’Brien et al., <xref ref-type="bibr" rid="B102">2005</xref>), and these breeds are considered as natural models for PD. Dogs with CMSD are clinically normal until 3–6 months of age when they first develop the clinical signs of cerebellar ataxia (O’Brien et al., <xref ref-type="bibr" rid="B102">2005</xref>). This progresses to akinesia (i.e., impairment in voluntary movement) and severe postural instability ultimately leading to euthanasia by 1–2 years of age due to a severe decline in quality of life (O’Brien et al., <xref ref-type="bibr" rid="B102">2005</xref>). The histological hallmark of CMSD includes the loss of cerebellar Purkinje cells with degeneration of the olivary nucleus, substantia nigra, and caudate nucleus (deLahunta and Averill, <xref ref-type="bibr" rid="B33">1976</xref>; Montgomery and Storts, <xref ref-type="bibr" rid="B98">1983</xref>), areas of which are relevant to PD etiopathogenesis. Interestingly, the CMSD locus includes a segment that contains <italic>PARK2</italic>, the gene for parkin, and mutations in human <italic>PARK2</italic> is known to cause familial PD, which has clinical and pathological similarities to CMSD (O’Brien et al., <xref ref-type="bibr" rid="B102">2005</xref>).</p>
<p>We acknowledge that there is no perfect animal model for investigating neurodegenerative disorders, and it should be recognized that the canine model also has limitations. For example, it has been recently shown that dogs lack aldehyde oxidases (AOXs) which catalyze the oxidation of aldehydes or N-heterocycles (Terao et al., <xref ref-type="bibr" rid="B142">2006</xref>). This fact has physiological, pharmacological, and toxicological relevance since AOXs represent an important metabolic pathway that oxidizes numerous endogenous and exogenous substrates of biologic importance (Garattini et al., <xref ref-type="bibr" rid="B43">2003</xref>). Also, humans and dogs have different CYP3A isoforms (i.e., canine CYP3A12 is equivalent to human CYP3A4) which impact species-specific differences in permeability, toxicity, and metabolism analysis between <italic>in vitro</italic> and <italic>in vivo</italic> systems (Zhang et al., <xref ref-type="bibr" rid="B153">2001</xref>). A detailed assessment of drug transporters and metabolic enzymes expression <italic>in vitro</italic> is key to establish the predictive performance of these in systems recapitulating <italic>in vivo</italic> drug absorption and metabolism. Also, it is possible that differences in activity and substrate specificity/inhibitors and inducers are observed in the dog; therefore, utilizing <italic>in vitro</italic> systems from multiple different species would allow the supplementation of other <italic>in vitro</italic> systems that do not fully mimic human physiology on their own (Zhang et al., <xref ref-type="bibr" rid="B153">2001</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="conclusion">
<title>Conclusion</title>
<p>Recent analyses suggest that one of the most expensive therapeutic areas having poor success rate in terms of drug research and discovery (R&amp;D) is neurology (Kola and Landis, <xref ref-type="bibr" rid="B80">2004</xref>). One barrier to achieving lower attrition rates in neurology drug R&amp;D is the lack of utilization of appropriate naturally occurring models of disease, such as CCD as a model for human AD. The dog is a particularly relevant species since it shares multiple epidemiologic features with humans, including similarities in diet and their intestinal microbiomes. Furthermore, CCD dogs can be used as a natural model for both AD, as well as PD, since clinical trials can be performed in dogs to assess the efficacy of novel treatments prior to human trials (i.e., reverse extrapolation). Importantly, since organoids are derived from individuals with different genotypes and environmental exposures, they are a highly relevant model system for <italic>ex vivo</italic> studies, and are of value in “precision medicine.” Integration of organoid culture systems with GOAC technology will maintain patient-specific genetic and epigenetic disease characteristics influencing inter-patient drug screening during the early exploratory R&amp;D phase. We predict that it will be possible to predict the outcome of novel therapeutics prior to human trials by combining data from GOAC models and clinical trials with dogs serving as a model for naturally occurring neurodegenerative diseases.</p>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>YA and JM conceived the idea for the review. YA searched and reviewed the literature, drafted and revised the manuscript. AW further searched and reviewed the AD and PD literature and revised the manuscript. JM, DB, KA, AJ, AK, and HK reviewed and edited the manuscript. All authors read and approved the final manuscript.</p>
</sec>
<sec id="s6">
<title>Conflict of Interest Statement</title>
<p>JM, AJ, KA, and HK are founders of a company, 3D Health Solutions. JM, AJ, and KA are founders of a company, LEAH (Life Engine Animal Health, Inc.) located in Rochester, MN, USA. AK has an equity interest in PK Biosciences Corporation located in Ames, IA, USA. The terms of this arrangement have been reviewed and approved by Iowa State University in accordance with its conflict of interest policies. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>The earlier version of this manuscript has been released as a Pre-Print at <ext-link ext-link-type="uri" xlink:href="http://Preprints.org">www.Preprints.org</ext-link> (Ambrosini et al., <xref ref-type="bibr" rid="B6">2019</xref>).</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported in part by the ACVIM Advanced Research Training Fellowship, Bio &amp; Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science and ICT (2018M3A9H3025030 to HK), Cancer Research Institute (UTA18-000889 to HK), Alternative Research and Development Foundation (UTA18-001198 to HK).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adjei</surname><given-names>A. A.</given-names></name><name><surname>Christian</surname><given-names>M.</given-names></name><name><surname>Ivy</surname><given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Novel designs and end points for phase II clinical trials</article-title>. <source/>Clin. Cancer Res.
<volume>15</volume>, <fpage>1866</fpage>–<lpage>1872</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-08-2035</pub-id><pub-id pub-id-type="pmid">19276272</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>M.</given-names></name><name><surname>Puzan</surname><given-names>M.</given-names></name><name><surname>Koppes</surname><given-names>D. A.</given-names></name></person-group> (<year>in press</year>). <article-title>Gut-brain-axis on a chip: a microfluidic model of the enteroendocrine-enteric nervous system interface:1</article-title>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.northeastern.edu/rise/presentations/gut-brain-axis-on-a-chip-a-microfluidic-model-of-the-enteroendocrine-enteric-nervous-system-interface/">https://www.northeastern.edu/rise/presentations/gut-brain-axis-on-a-chip-a-microfluidic-model-of-the-enteroendocrine-enteric-nervous-system-interface/</ext-link></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alcendor</surname><given-names>D. J.</given-names></name><name><surname>Charest</surname><given-names>A. M.</given-names></name><name><surname>Zhu</surname><given-names>W. Q.</given-names></name><name><surname>Vigil</surname><given-names>H. E.</given-names></name><name><surname>Knobel</surname><given-names>S. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus</article-title>. <source/>J. Neuroinflammation
<volume>9</volume>:<fpage>95</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-95</pub-id><pub-id pub-id-type="pmid">22607552</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alcendor</surname><given-names>D. J.</given-names></name><name><surname>Block</surname><given-names>F. E.</given-names><suffix>III.</suffix></name><name><surname>Cliffel</surname><given-names>D. E.</given-names></name><name><surname>Daniels</surname><given-names>J. S.</given-names></name><name><surname>Ellacott</surname><given-names>K. L. J.</given-names></name><name><surname>Goodwin</surname><given-names>C. R.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Neurovascular unit on a chip: implications for translational applications</article-title>. <source/>Stem Cell Res. Ther.
<volume>4</volume>:<fpage>S18</fpage>. <pub-id pub-id-type="doi">10.1186/scrt379</pub-id><pub-id pub-id-type="pmid">24564885</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alessandri</surname><given-names>G.</given-names></name><name><surname>Milani</surname><given-names>C.</given-names></name><name><surname>Mancabelli</surname><given-names>L.</given-names></name><name><surname>Mangifesta</surname><given-names>M.</given-names></name><name><surname>Lugli</surname><given-names>G. A.</given-names></name><name><surname>Viappiani</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>Metagenomic dissection of the canine gut microbiota: insights into taxonomic, metabolic and nutritional features</article-title>. <source/>Environ. Microbiol.
<volume>21</volume>, <fpage>1331</fpage>–<lpage>1343</lpage>. <pub-id pub-id-type="doi">10.1111/1462-2920.14540</pub-id><pub-id pub-id-type="pmid">30680877</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosini</surname><given-names>Y.</given-names></name><name><surname>Borcherding</surname><given-names>D.</given-names></name><name><surname>Kanthasamy</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Jergens</surname><given-names>A.</given-names></name><name><surname>Allenspach</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>The role of the gut-brain axis in neurodegenerative diseases and relevance of the canine model: a review</article-title>. <source/>Preprints
<volume>2019</volume>:<fpage>2019010275</fpage>
<pub-id pub-id-type="doi">10.20944/preprints201901.0275.v1</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>S.</given-names></name><name><surname>Luffer-Atlas</surname><given-names>D.</given-names></name><name><surname>Knadler</surname><given-names>M. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Predicting circulating human metabolites: how good are we?</article-title>
<source/>Chem. Res. Toxicol.
<volume>22</volume>, <fpage>243</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1021/tx8004086</pub-id><pub-id pub-id-type="pmid">19138063</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ano</surname><given-names>Y.</given-names></name><name><surname>Sakudo</surname><given-names>A.</given-names></name><name><surname>Nakayama</surname><given-names>H.</given-names></name><name><surname>Onodera</surname><given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>Uptake and dynamics of infectious prion protein in the intestine</article-title>. <source/>Protein Pept. Lett.
<volume>16</volume>, <fpage>247</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.2174/092986609787601642</pub-id><pub-id pub-id-type="pmid">19275737</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asano</surname><given-names>Y.</given-names></name><name><surname>Hiramoto</surname><given-names>T.</given-names></name><name><surname>Nishino</surname><given-names>R.</given-names></name><name><surname>Aiba</surname><given-names>Y.</given-names></name><name><surname>Kimura</surname><given-names>T.</given-names></name><name><surname>Yoshihara</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice</article-title>. <source/>Am. J. Physiol. Gastrointest. Liver Physiol.
<volume>303</volume>, <fpage>G1288</fpage>–<lpage>G1295</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00341.2012</pub-id><pub-id pub-id-type="pmid">23064760</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asti</surname><given-names>A.</given-names></name><name><surname>Gioglio</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?</article-title>
<source/>J. Alzheimers Dis.
<volume>39</volume>, <fpage>169</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.3233/jad-131394</pub-id><pub-id pub-id-type="pmid">24150108</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attems</surname><given-names>J.</given-names></name><name><surname>Jellinger</surname><given-names>K. A.</given-names></name><name><surname>Lintner</surname><given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy</article-title>. <source/>Acta Neuropathol.
<volume>110</volume>, <fpage>222</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-005-1064-y</pub-id><pub-id pub-id-type="pmid">16133541</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attems</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms</article-title>. <source/>Acta Neuropathol.
<volume>110</volume>, <fpage>345</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-005-1074-9</pub-id><pub-id pub-id-type="pmid">16170565</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axelsson</surname><given-names>E.</given-names></name><name><surname>Ratnakumar</surname><given-names>A.</given-names></name><name><surname>Arendt</surname><given-names>M.-L.</given-names></name><name><surname>Maqbool</surname><given-names>K.</given-names></name><name><surname>Webster</surname><given-names>M. T.</given-names></name><name><surname>Perloski</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The genomic signature of dog domestication reveals adaptation to a starch-rich diet</article-title>. <source/>Nature
<volume>495</volume>, <fpage>360</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1038/nature11837</pub-id><pub-id pub-id-type="pmid">23354050</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aziz</surname><given-names>Q.</given-names></name><name><surname>Doré</surname><given-names>J.</given-names></name><name><surname>Emmanuel</surname><given-names>A.</given-names></name><name><surname>Guarner</surname><given-names>F.</given-names></name><name><surname>Quigley</surname><given-names>E. M. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Gut microbiota and gastrointestinal health: current concepts and future directions</article-title>. <source/>Neurogastroenterol. Motil.
<volume>25</volume>, <fpage>4</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1111/nmo.12046</pub-id><pub-id pub-id-type="pmid">23279728</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bienenstock</surname><given-names>J.</given-names></name><name><surname>Kunze</surname><given-names>W.</given-names></name><name><surname>Forsythe</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Microbiota and the gut-brain axis</article-title>. <source/>Nutr. Rev.
<volume>73</volume>, <fpage>28</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1093/nutrit/nuv019</pub-id><pub-id pub-id-type="pmid">26175487</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borràs</surname><given-names>D.</given-names></name><name><surname>Ferrer</surname><given-names>I.</given-names></name><name><surname>Pumarola</surname><given-names>M.</given-names></name></person-group> (<year>1999</year>). <article-title>Age-related changes in the brain of the dog</article-title>. <source/>Vet. Pathol.
<volume>36</volume>, <fpage>202</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1354/vp.36-3-202</pub-id><pub-id pub-id-type="pmid">10332828</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Böttner</surname><given-names>M.</given-names></name><name><surname>Zorenkov</surname><given-names>D.</given-names></name><name><surname>Hellwig</surname><given-names>I.</given-names></name><name><surname>Barrenschee</surname><given-names>M.</given-names></name><name><surname>Harde</surname><given-names>J.</given-names></name><name><surname>Fricke</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Expression pattern and localization of α-synuclein in the human enteric nervous system</article-title>. <source/>Neurobiol. Dis.
<volume>48</volume>, <fpage>474</fpage>–<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.07.018</pub-id><pub-id pub-id-type="pmid">22850485</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname><given-names>H.</given-names></name><name><surname>de Vos</surname><given-names>R. A. I.</given-names></name><name><surname>Bohl</surname><given-names>J.</given-names></name><name><surname>Tredici</surname><given-names>K. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Gastric α-synuclein immunoreactive inclusions in meissner’s and auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology</article-title>. <source/>Neurosci. Lett.
<volume>396</volume>, <fpage>67</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2005.11.012</pub-id><pub-id pub-id-type="pmid">16330147</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breydo</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>J. W.</given-names></name><name><surname>Uversky</surname><given-names>V. N.</given-names></name></person-group> (<year>2012</year>). <article-title>α-synuclein misfolding and Parkinson’s disease</article-title>. <source/>Biochim. Biophys. Acta
<volume>1822</volume>, <fpage>261</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2011.10.002</pub-id><pub-id pub-id-type="pmid">22024360</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browning</surname><given-names>K. N.</given-names></name><name><surname>Travagli</surname><given-names>R. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions</article-title>. <source/>Compr. Physiol.
<volume>4</volume>, <fpage>1339</fpage>–<lpage>1368</lpage>. <pub-id pub-id-type="doi">10.1002/cphy.c130055</pub-id><pub-id pub-id-type="pmid">25428846</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brundin</surname><given-names>P.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Kordower</surname><given-names>J. H.</given-names></name></person-group> (<year>2016</year>). <article-title>How strong is the evidence that Parkinson’s disease is a prion disorder?</article-title>
<source/>Curr. Opin. Neurol.
<volume>29</volume>, <fpage>459</fpage>–<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0000000000000349</pub-id><pub-id pub-id-type="pmid">27257944</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carabotti</surname><given-names>M.</given-names></name><name><surname>Scirocco</surname><given-names>A.</given-names></name><name><surname>Maselli</surname><given-names>M. A.</given-names></name><name><surname>Severi</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems</article-title>. <source/>Ann. Gastroenterol.
<volume>28</volume>, <fpage>203</fpage>–<lpage>209</lpage>. <pub-id pub-id-type="pmid">25830558</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>L.</given-names></name><name><surname>Borcherding</surname><given-names>D. C.</given-names></name><name><surname>Kingsbury</surname><given-names>D.</given-names></name><name><surname>Atherly</surname><given-names>T.</given-names></name><name><surname>Ambrosini</surname><given-names>Y. M.</given-names></name><name><surname>Bourgois-Mochel</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Adult canine intestinal derived organoids: a novel <italic>in vitro</italic> system for translational research in comparative gastroenterology</article-title>. <source/>bioRxiv [Preprint]. <pub-id pub-id-type="doi">10.1101/466409</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhuri</surname><given-names>K. R.</given-names></name><name><surname>Healy</surname><given-names>D. G.</given-names></name><name><surname>Schapira</surname><given-names>A. H. V.</given-names></name></person-group> (<year>2006</year>). <article-title>Non-motor symptoms of Parkinson’s disease: diagnosis and management</article-title>. <source/>Lancet Neurol.
<volume>5</volume>, <fpage>235</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(06)70373-8</pub-id><pub-id pub-id-type="pmid">16488379</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.-H.</given-names></name><name><surname>Lin</surname><given-names>C.-L.</given-names></name><name><surname>Kao</surname><given-names>C.-H.</given-names></name></person-group> (<year>2016</year>). <article-title>Irritable bowel syndrome is associated with an increased risk of dementia: a nationwide population-based study</article-title>. <source/>PLoS One
<volume>11</volume>:<fpage>e0144589</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0144589</pub-id><pub-id pub-id-type="pmid">26731277</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choe</surname><given-names>A.</given-names></name><name><surname>Ha</surname><given-names>S. K.</given-names></name><name><surname>Choi</surname><given-names>I.</given-names></name><name><surname>Choi</surname><given-names>N.</given-names></name><name><surname>Sung</surname><given-names>J. H.</given-names></name></person-group> (<year>2017</year>). <article-title>Microfluidic gut-liver chip for reproducing the first pass metabolism</article-title>. <source/>Biomed. Microdevices
<volume>19</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1007/s10544-016-0143-2</pub-id><pub-id pub-id-type="pmid">28074384</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coelho</surname><given-names>L. P.</given-names></name><name><surname>Kultima</surname><given-names>J. R.</given-names></name><name><surname>Costea</surname><given-names>P. I.</given-names></name><name><surname>Fournier</surname><given-names>C.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Czarnecki-Maulden</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Similarity of the dog and human gut microbiomes in gene content and response to diet</article-title>. <source/>Microbiome
<volume>6</volume>:<fpage>72</fpage>. <pub-id pub-id-type="doi">10.1186/s40168-018-0450-3</pub-id><pub-id pub-id-type="pmid">29669589</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colle</surname><given-names>M.-A.</given-names></name><name><surname>Hauw</surname><given-names>J.-J.</given-names></name><name><surname>Crespeau</surname><given-names>F.</given-names></name><name><surname>Uchihara</surname><given-names>T.</given-names></name><name><surname>Akiyama</surname><given-names>H.</given-names></name><name><surname>Checler</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Vascular and parenchymal Aβ deposition in the aging dog: correlation with behavior</article-title>. <source/>Neurobiol. Aging
<volume>21</volume>, <fpage>695</fpage>–<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1016/S0197-4580(00)00113-5</pub-id><pub-id pub-id-type="pmid">11016539</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cucullo</surname><given-names>L.</given-names></name><name><surname>Hossain</surname><given-names>M.</given-names></name><name><surname>Puvenna</surname><given-names>V.</given-names></name><name><surname>Marchi</surname><given-names>N.</given-names></name><name><surname>Janigro</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of shear stress in blood-brain barrier endothelial physiology</article-title>. <source/>BMC Neurosci.
<volume>12</volume>:<fpage>40</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2202-12-40</pub-id><pub-id pub-id-type="pmid">21569296</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>B. J.</given-names></name><name><surname>Pike</surname><given-names>C. J.</given-names></name><name><surname>Shankle</surname><given-names>R.</given-names></name><name><surname>Cotman</surname><given-names>C. W.</given-names></name></person-group> (<year>1996</year>). <article-title>β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer’s disease</article-title>. <source/>Neurobiol. Aging
<volume>17</volume>, <fpage>921</fpage>–<lpage>933</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-4580(96)00170-4</pub-id><pub-id pub-id-type="pmid">9363804</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danzer</surname><given-names>K. M.</given-names></name><name><surname>Kranich</surname><given-names>L. R.</given-names></name><name><surname>Ruf</surname><given-names>W. P.</given-names></name><name><surname>Cagsal-Getkin</surname><given-names>O.</given-names></name><name><surname>Winslow</surname><given-names>A. R.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Exosomal cell-to-cell transmission of α synuclein oligomers</article-title>. <source/>Mol. Neurodegener.
<volume>7</volume>:<fpage>42</fpage>. <pub-id pub-id-type="doi">10.1186/1750-1326-7-42</pub-id><pub-id pub-id-type="pmid">22920859</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>P. R.</given-names></name><name><surname>Head</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Prevention approaches in a preclinical canine model of Alzheimer’s disease: benefits and challenges</article-title>. <source/>Front. Pharmacol.
<volume>5</volume>:<fpage>47</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2014.00047</pub-id><pub-id pub-id-type="pmid">24711794</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>deLahunta</surname><given-names>A.</given-names></name><name><surname>Averill</surname><given-names>D. R.</given-names><suffix>Jr.</suffix></name></person-group> (<year>1976</year>). <article-title>Hereditary cerebellar cortical and extrapyramidal nuclear abiotrophy in kerry blue terriers</article-title>. <source/>J. Am. Vet. Med. Assoc.
<volume>168</volume>, <fpage>1119</fpage>–<lpage>1124</lpage>. <pub-id pub-id-type="pmid">931776</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lartigue</surname><given-names>G.</given-names></name><name><surname>de La Serre</surname><given-names>C. B.</given-names></name><name><surname>Raybould</surname><given-names>H. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin</article-title>. <source/>Physiol. Behav.
<volume>105</volume>, <fpage>100</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2011.02.040</pub-id><pub-id pub-id-type="pmid">21376066</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delzenne</surname><given-names>N. M.</given-names></name><name><surname>Neyrinck</surname><given-names>A. M.</given-names></name><name><surname>Cani</surname><given-names>P. D.</given-names></name></person-group> (<year>2011</year>). <article-title>Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome</article-title>. <source/>Microb. Cell Fact.
<volume>10</volume>:<fpage>S10</fpage>. <pub-id pub-id-type="doi">10.1186/1475-2859-10-S1-S10</pub-id><pub-id pub-id-type="pmid">21995448</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinan</surname><given-names>T. G.</given-names></name><name><surname>Quigley</surname><given-names>E. M. M.</given-names></name><name><surname>Ahmed</surname><given-names>S. M. M.</given-names></name><name><surname>Scully</surname><given-names>P.</given-names></name><name><surname>O’Brien</surname><given-names>S.</given-names></name><name><surname>O’Mahony</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?</article-title>
<source/>Gastroenterology
<volume>130</volume>, <fpage>304</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2005.11.033</pub-id><pub-id pub-id-type="pmid">16472586</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteve</surname><given-names>E.</given-names></name><name><surname>Ricart</surname><given-names>W.</given-names></name><name><surname>Fernández-real</surname><given-names>J.-M.</given-names></name></person-group> (<year>2011</year>). <article-title>Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?</article-title>
<source/>Curr. Opin. Clin. Nutr. Metab. Care
<volume>14</volume>, <fpage>483</fpage>–<lpage>490</lpage>. <pub-id pub-id-type="doi">10.1097/mco.0b013e328348c06d</pub-id><pub-id pub-id-type="pmid">21681087</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flint</surname><given-names>H. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Obesity and the gut microbiota</article-title>. <source/>J. Clin. Gastroenterol.
<volume>45</volume>, <fpage>S128</fpage>–<lpage>S132</lpage>. <pub-id pub-id-type="doi">10.1097/MCG.0b013e31821f44c4</pub-id><pub-id pub-id-type="pmid">21992951</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>J. A.</given-names></name><name><surname>Rinaman</surname><given-names>L.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name></person-group> (<year>2017</year>). <article-title>Stress and the gut-brain axis: regulation by the microbiome</article-title>. <source/>Neurobiol. Stress
<volume>7</volume>, <fpage>124</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1016/j.ynstr.2017.03.001</pub-id><pub-id pub-id-type="pmid">29276734</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedland</surname><given-names>R. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Mechanisms of molecular mimicry involving the microbiota in neurodegeneration</article-title>. <source/>J. Alzheimers Dis.
<volume>45</volume>, <fpage>349</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.3233/jad-142841</pub-id><pub-id pub-id-type="pmid">25589730</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galloway</surname><given-names>S.</given-names></name><name><surname>Jian</surname><given-names>L.</given-names></name><name><surname>Johnsen</surname><given-names>R.</given-names></name><name><surname>Chew</surname><given-names>S.</given-names></name><name><surname>Mamo</surname><given-names>J. C. L.</given-names></name></person-group> (<year>2007</year>). <article-title>β-amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding</article-title>. <source/>J. Nutr. Biochem.
<volume>18</volume>, <fpage>279</fpage>–<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1016/j.jnutbio.2006.07.003</pub-id><pub-id pub-id-type="pmid">16962759</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galloway</surname><given-names>S.</given-names></name><name><surname>Takechi</surname><given-names>R.</given-names></name><name><surname>Pallebage-Gamarallage</surname><given-names>M. M. S.</given-names></name><name><surname>Dhaliwal</surname><given-names>S. S.</given-names></name><name><surname>Mamo</surname><given-names>J. C. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Amyloid-β colocalizes with apolipoprotein B in absorptive cells of the small intestine</article-title>. <source/>Lipids Health Dis.
<volume>8</volume>:<fpage>46</fpage>. <pub-id pub-id-type="doi">10.1186/1476-511X-8-46</pub-id><pub-id pub-id-type="pmid">19845970</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Schwarzschild</surname><given-names>M. A.</given-names></name><name><surname>Ascherio</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>A prospective study of bowel movement frequency and risk of Parkinson’s disease</article-title>. <source/>Am. J. Epidemiol.
<volume>174</volume>, <fpage>546</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwr119</pub-id><pub-id pub-id-type="pmid">21719744</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garattini</surname><given-names>E.</given-names></name><name><surname>Mendel</surname><given-names>R.</given-names></name><name><surname>Romão</surname><given-names>M. J.</given-names></name><name><surname>Wright</surname><given-names>R.</given-names></name><name><surname>Terao</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology</article-title>. <source/>Biochem. J.
<volume>372</volume>, <fpage>15</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1042/bj20030121</pub-id><pub-id pub-id-type="pmid">12578558</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goedert</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Alzheimer’s and Parkinson’s diseases: the prion concept in relation to assembled Aβ, tau, and α-synuclein</article-title>. <source/>Science
<volume>349</volume>:<fpage>1255555</fpage>. <pub-id pub-id-type="doi">10.1126/science.1255555</pub-id><pub-id pub-id-type="pmid">26250687</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>A.</given-names></name><name><surname>Turkalp</surname><given-names>Z. T.</given-names></name><name><surname>Munoz</surname><given-names>D. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Enteric α-synuclein expression is increased in Parkinson’s disease but not Alzheimer’s disease</article-title>. <source/>Mov. Disord.
<volume>28</volume>, <fpage>237</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1002/mds.25298</pub-id><pub-id pub-id-type="pmid">23362176</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>L. M.</given-names></name><name><surname>Williamson</surname><given-names>I.</given-names></name><name><surname>Piedrahita</surname><given-names>J. A.</given-names></name><name><surname>Blikslager</surname><given-names>A. T.</given-names></name><name><surname>Magness</surname><given-names>S. T.</given-names></name></person-group> (<year>2013</year>). <article-title>Cell lineage identification and stem cell culture in a porcine model for the study of intestinal epithelial regeneration</article-title>. <source/>PLoS One
<volume>8</volume>:<fpage>e66465</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0066465</pub-id><pub-id pub-id-type="pmid">23840480</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Götz</surname><given-names>J.</given-names></name><name><surname>Ittner</surname><given-names>L. M.</given-names></name><name><surname>Schonrock</surname><given-names>N.</given-names></name><name><surname>Cappai</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>An update on the toxicity of Aβ in Alzheimer’s disease</article-title>. <source/>Neuropsychiatr. Dis. Treat.
<volume>4</volume>, <fpage>1033</fpage>–<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.2147/ndt.s3016</pub-id><pub-id pub-id-type="pmid">19337449</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grasset</surname><given-names>E.</given-names></name><name><surname>Puel</surname><given-names>A.</given-names></name><name><surname>Charpentier</surname><given-names>J.</given-names></name><name><surname>Collet</surname><given-names>X.</given-names></name><name><surname>Christensen</surname><given-names>J. E.</given-names></name><name><surname>Tercé</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A specific gut microbiota dysbiosis of type 2 diabetic mice induces GLP-1 resistance through an enteric NO-dependent and gut-brain axis mechanism</article-title>. <source/>Cell Metab.
<volume>25</volume>, <fpage>1075.e5</fpage>–<lpage>1090.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2017.04.013</pub-id><pub-id pub-id-type="pmid">28467926</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grenham</surname><given-names>S.</given-names></name><name><surname>Clarke</surname><given-names>G.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Brain-gut-microbe communication in health and disease</article-title>. <source/>Front. Physiol.
<volume>2</volume>:<fpage>94</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2011.00094</pub-id><pub-id pub-id-type="pmid">22162969</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grider</surname><given-names>J. R.</given-names></name><name><surname>Piland</surname><given-names>B. E.</given-names></name></person-group> (<year>2007</year>). <article-title>The peristaltic reflex induced by short-chain fatty acids is mediated by sequential release of 5-HT and neuronal CGRP but not BDNF</article-title>. <source/>Am. J. Physiol. Gastrointest. Liver Physiol.
<volume>292</volume>, <fpage>G429</fpage>–<lpage>G437</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00376.2006</pub-id><pub-id pub-id-type="pmid">16973914</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>A. M.</given-names></name><name><surname>Roberson</surname><given-names>E. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Mouse models of Alzheimer’s disease</article-title>. <source/>Brain Res. Bull.
<volume>88</volume>, <fpage>3</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.11.017</pub-id><pub-id pub-id-type="pmid">22142973</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haller</surname><given-names>D.</given-names></name><name><surname>Bode</surname><given-names>C.</given-names></name><name><surname>Hammes</surname><given-names>W. P.</given-names></name><name><surname>Pfeifer</surname><given-names>A. M. A.</given-names></name><name><surname>Schiffrin</surname><given-names>E. J.</given-names></name><name><surname>Blum</surname><given-names>S.</given-names></name></person-group> (<year>2000</year>). <article-title>Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures</article-title>. <source/>Gut
<volume>47</volume>, <fpage>79</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1136/gut.47.1.79</pub-id><pub-id pub-id-type="pmid">10861268</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hargis</surname><given-names>K. E.</given-names></name><name><surname>Blalock</surname><given-names>E. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Transcriptional signatures of brain aging and Alzheimer’s disease: what are our rodent models telling us?</article-title>
<source/>Behav. Brain Res.
<volume>322</volume>, <fpage>311</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2016.05.007</pub-id><pub-id pub-id-type="pmid">27155503</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasegawa</surname><given-names>M.</given-names></name><name><surname>Fujiwara</surname><given-names>H.</given-names></name><name><surname>Nonaka</surname><given-names>T.</given-names></name><name><surname>Wakabayashi</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>V. M.-Y.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions</article-title>. <source/>J. Biol. Chem.
<volume>277</volume>, <fpage>49071</fpage>–<lpage>49076</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M208046200</pub-id><pub-id pub-id-type="pmid">12377775</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Head</surname><given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>A canine model of human aging and Alzheimer’s disease</article-title>. <source/>Biochim. Biophys. Acta
<volume>1832</volume>, <fpage>1384</fpage>–<lpage>1389</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2013.03.016</pub-id><pub-id pub-id-type="pmid">23528711</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herzig</surname><given-names>M. C.</given-names></name><name><surname>van Nostrand</surname><given-names>W. E.</given-names></name><name><surname>Jucker</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Mechanism of cerebral β-amyloid angiopathy: murine and cellular models</article-title>. <source/>Brain Pathol.
<volume>16</volume>, <fpage>40</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3639.2006.tb00560.x</pub-id><pub-id pub-id-type="pmid">16612981</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilton</surname><given-names>D.</given-names></name><name><surname>Stephens</surname><given-names>M.</given-names></name><name><surname>Kirk</surname><given-names>L.</given-names></name><name><surname>Edwards</surname><given-names>P.</given-names></name><name><surname>Potter</surname><given-names>R.</given-names></name><name><surname>Zajicek</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease</article-title>. <source/>Acta Neuropathol.
<volume>127</volume>, <fpage>235</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-013-1214-6</pub-id><pub-id pub-id-type="pmid">24240814</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>J. M.</given-names></name><name><surname>Creevy</surname><given-names>K. E.</given-names></name><name><surname>Franks</surname><given-names>A.</given-names></name><name><surname>O’Neill</surname><given-names>D. G.</given-names></name><name><surname>Promislow</surname><given-names>D. E. L.</given-names></name></person-group> (<year>2018</year>). <article-title>The companion dog as a model for human aging and mortality</article-title>. <source/>Aging Cell
<volume>17</volume>:<fpage>e12737</fpage>. <pub-id pub-id-type="doi">10.1111/acel.12737</pub-id><pub-id pub-id-type="pmid">29457329</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornig</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness</article-title>. <source/>Curr. Opin. Rheumatol.
<volume>25</volume>, <fpage>488</fpage>–<lpage>795</lpage>. <pub-id pub-id-type="doi">10.1097/bor.0b013e32836208de</pub-id><pub-id pub-id-type="pmid">23656715</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houser</surname><given-names>M. C.</given-names></name><name><surname>Tansey</surname><given-names>M. G.</given-names></name></person-group> (<year>2017</year>). <article-title>The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?</article-title>
<source/>NPJ Parkinsons Dis.
<volume>3</volume>:<fpage>3</fpage>. <pub-id pub-id-type="doi">10.1038/s41531-016-0002-0</pub-id><pub-id pub-id-type="pmid">28649603</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hufnagel</surname><given-names>D. A.</given-names></name><name><surname>Tükel</surname><given-names>Ç.</given-names></name><name><surname>Chapman</surname><given-names>M. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Disease to dirt: the biology of microbial amyloids</article-title>. <source/>PLoS Pathog.
<volume>9</volume>:<fpage>e1003740</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003740</pub-id><pub-id pub-id-type="pmid">24278013</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iadanza</surname><given-names>M. G.</given-names></name><name><surname>Jackson</surname><given-names>M. P.</given-names></name><name><surname>Hewitt</surname><given-names>E. W.</given-names></name><name><surname>Ranson</surname><given-names>N. A.</given-names></name><name><surname>Radford</surname><given-names>S. E.</given-names></name></person-group> (<year>2018</year>). <article-title>A new era for understanding amyloid structures and disease</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>19</volume>, <fpage>755</fpage>–<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-018-0060-8</pub-id><pub-id pub-id-type="pmid">30237470</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insua</surname><given-names>D.</given-names></name><name><surname>Corredoira</surname><given-names>A.</given-names></name><name><surname>González-Martínez</surname><given-names>Á.</given-names></name><name><surname>Suárez</surname><given-names>M.-L.</given-names></name><name><surname>Santamarina</surname><given-names>G.</given-names></name><name><surname>Sarasa</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Expression of P75 NTR, a marker for basal forebrain cholinergic neurons, in young and aged dogs with or without cognitive dysfunction syndrome</article-title>. <source/>J. Alzheimers Dis.
<volume>28</volume>, <fpage>291</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.3233/jad-2011-110905</pub-id><pub-id pub-id-type="pmid">21971402</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishihara</surname><given-names>T.</given-names></name><name><surname>Gondo</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Uchino</surname><given-names>F.</given-names></name><name><surname>Ikeda</surname><given-names>S.-I.</given-names></name><name><surname>Allsop</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Immunohistochemical and immunoelectron microscopical characterization of cerebrovascular and senile plaque amyloid in aged dogs’ brains</article-title>. <source/>Brain Res.
<volume>548</volume>, <fpage>196</fpage>–<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(91)91122-h</pub-id><pub-id pub-id-type="pmid">1868335</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>L. M.</given-names></name><name><surname>Aravind</surname><given-names>L.</given-names></name><name><surname>Coon</surname><given-names>S. L.</given-names></name><name><surname>Klein</surname><given-names>D. C.</given-names></name><name><surname>Koonin</surname><given-names>E. V.</given-names></name></person-group> (<year>2004</year>). <article-title>Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role?</article-title>
<source/>Trends Genet.
<volume>20</volume>, <fpage>292</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2004.05.007</pub-id><pub-id pub-id-type="pmid">15219393</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamieson</surname><given-names>J. J.</given-names></name><name><surname>Searson</surname><given-names>P. C.</given-names></name><name><surname>Gerecht</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Engineering the human blood-brain barrier <italic>in vitro</italic></article-title>. <source/>J. Biol. Eng.
<volume>11</volume>:<fpage>37</fpage>. <pub-id pub-id-type="doi">10.1186/s13036-017-0076-1</pub-id><pub-id pub-id-type="pmid">29213304</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenner</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Oxidative stress in Parkinson’s disease</article-title>. <source/>Ann. Neurol.
<volume>53</volume>, <fpage>S26</fpage>–<lpage>S38</lpage>. <pub-id pub-id-type="doi">10.1002/ana.10483</pub-id><pub-id pub-id-type="pmid">12666096</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Huang</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>The gut microbiota and Alzheimer’s disease</article-title>. <source/>J. Alzheimers Dis.
<volume>58</volume>, <fpage>1</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-161141</pub-id><pub-id pub-id-type="pmid">28372330</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>K. A.</given-names></name><name><surname>Fox</surname><given-names>N. C.</given-names></name><name><surname>Sperling</surname><given-names>R. A.</given-names></name><name><surname>Klunk</surname><given-names>W. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Brain imaging in Alzheimer disease</article-title>. <source/>Cold Spring Harb. Perspect. Med.
<volume>2</volume>:<fpage>a006213</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a006213</pub-id><pub-id pub-id-type="pmid">22474610</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kihara</surname><given-names>N.</given-names></name><name><surname>Fujimura</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>I.</given-names></name><name><surname>Itoh</surname><given-names>E.</given-names></name><name><surname>Inui</surname><given-names>A.</given-names></name><name><surname>Fujimiya</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats</article-title>. <source/>Am. J. Physiol. Gastrointest. Liver Physiol.
<volume>280</volume>, <fpage>G406</fpage>–<lpage>G419</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.2001.280.3.g406</pub-id><pub-id pub-id-type="pmid">11171623</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Huh</surname><given-names>D.</given-names></name><name><surname>Hamilton</surname><given-names>G.</given-names></name><name><surname>Ingber</surname><given-names>D. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow</article-title>. <source/>Lab Chip
<volume>12</volume>, <fpage>2165</fpage>–<lpage>2174</lpage>. <pub-id pub-id-type="doi">10.1039/c2lc40074j</pub-id><pub-id pub-id-type="pmid">22434367</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Ingber</surname><given-names>D. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Gut-on-a-chip microenvironment induces human intestinal cells to undergo villus differentiation</article-title>. <source/>Integr. Biol.
<volume>5</volume>, <fpage>1130</fpage>–<lpage>1140</lpage>. <pub-id pub-id-type="doi">10.1039/c3ib40126j</pub-id><pub-id pub-id-type="pmid">23817533</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Collins</surname><given-names>J. J.</given-names></name><name><surname>Ingber</surname><given-names>D. E.</given-names></name></person-group> (<year>2016a</year>). <article-title>Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>113</volume>, <fpage>E7</fpage>–<lpage>E15</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1522193112</pub-id><pub-id pub-id-type="pmid">26668389</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Choi</surname><given-names>J.-H.</given-names></name><name><surname>Bahinski</surname><given-names>A.</given-names></name><name><surname>Ingber</surname><given-names>D. E.</given-names></name></person-group> (<year>2016b</year>). <article-title>Co-culture of living microbiome with microengineered human intestinal villi in a gut-on-a-chip microfluidic device</article-title>. <source/>J. Vis. Exp.
<volume>114</volume>:<fpage>e54344</fpage>. <pub-id pub-id-type="doi">10.3791/54344</pub-id><pub-id pub-id-type="pmid">27684630</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>I.</given-names></name><name><surname>Inoue</surname><given-names>D.</given-names></name><name><surname>Maeda</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>T.</given-names></name><name><surname>Ichimura</surname><given-names>A.</given-names></name><name><surname>Miyauchi</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>108</volume>, <fpage>8030</fpage>–<lpage>8035</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1016088108</pub-id><pub-id pub-id-type="pmid">21518883</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>H.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Sakai</surname><given-names>H.</given-names></name><name><surname>Sakai</surname><given-names>Y.</given-names></name><name><surname>Fujii</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models</article-title>. <source/>Lab Chip
<volume>8</volume>, <fpage>741</fpage>–<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1039/b717091b</pub-id><pub-id pub-id-type="pmid">18432344</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingsbury</surname><given-names>D. D.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Qi</surname><given-names>Y.</given-names></name><name><surname>Fredericks</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>M Wannemuehler</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Optimizing the development and characterization of canine small intestinal crypt organoids as a research model</article-title>. <source/>Gastroenterology
<volume>152</volume>:<fpage>S353</fpage>
<pub-id pub-id-type="doi">10.1016/s0016-5085(17)31441-5</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>C.</given-names></name><name><surname>Westenberger</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Genetics of Parkinson’s disease</article-title>. <source/>Cold Spring Harb. Perspect. Med.
<volume>2</volume>:<fpage>a008888</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a008888</pub-id><pub-id pub-id-type="pmid">22315721</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kol</surname><given-names>A.</given-names></name><name><surname>Arzi</surname><given-names>B.</given-names></name><name><surname>Athanasiou</surname><given-names>K. A.</given-names></name><name><surname>Farmer</surname><given-names>D. L.</given-names></name><name><surname>Nolta</surname><given-names>J. A.</given-names></name><name><surname>Rebhun</surname><given-names>R. B.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Companion animals: translational scientist’s new best friends</article-title>. <source/>Sci. Transl. Med.
<volume>7</volume>:<fpage>308ps21</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aaa9116</pub-id><pub-id pub-id-type="pmid">26446953</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kola</surname><given-names>I.</given-names></name><name><surname>Landis</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Can the pharmaceutical industry reduce attrition rates?</article-title>
<source/>Nat. Rev. Drug Discov.
<volume>3</volume>, <fpage>711</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1038/nrd1470</pub-id><pub-id pub-id-type="pmid">15286737</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>S.-W.</given-names></name><name><surname>Liao</surname><given-names>K.-F.</given-names></name><name><surname>Lin</surname><given-names>C.-L.</given-names></name><name><surname>Sung</surname><given-names>F.-C.</given-names></name></person-group> (<year>2014</year>). <article-title>Irritable bowel syndrome correlates with increased risk of Parkinson’s disease in taiwan</article-title>. <source/>Eur. J. Epidemiol.
<volume>29</volume>, <fpage>57</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s10654-014-9878-3</pub-id><pub-id pub-id-type="pmid">24442494</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Ryan</surname><given-names>J.</given-names></name><name><surname>Andreescu</surname><given-names>C.</given-names></name><name><surname>Aizenstein</surname><given-names>H.</given-names></name><name><surname>Lim</surname><given-names>H. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Brainstem morphological changes in Alzheimer’s disease</article-title>. <source/>Neuroreport
<volume>26</volume>, <fpage>411</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1097/wnr.0000000000000362</pub-id><pub-id pub-id-type="pmid">25830491</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S. Y.</given-names></name><name><surname>Sung</surname><given-names>J. H.</given-names></name></person-group> (<year>2018</year>). <article-title>Gut-liver on a chip toward an <italic>in vitro</italic> model of hepatic steatosis</article-title>. <source/>Biotechnol. Bioeng.
<volume>115</volume>, <fpage>2817</fpage>–<lpage>2827</lpage>. <pub-id pub-id-type="doi">10.1002/bit.26793</pub-id><pub-id pub-id-type="pmid">29981260</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemche</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>). <article-title>Early life stress and epigenetics in late-Onset Alzheimer’s dementia: a systematic review</article-title>. <source/>Curr. Genomics
<volume>19</volume>, <fpage>522</fpage>–<lpage>602</lpage>. <pub-id pub-id-type="doi">10.2174/1389202919666171229145156</pub-id><pub-id pub-id-type="pmid">30386171</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesser</surname><given-names>G. T.</given-names></name></person-group> (<year>2002</year>). <article-title>Frequency of bowel movements and the future risk of Parkinson’s disease</article-title>. <source/>Neurology
<volume>58</volume>:<fpage>838</fpage>. <pub-id pub-id-type="doi">10.1212/wnl.58.5.838-a</pub-id><pub-id pub-id-type="pmid">11889266</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>B.</given-names></name><name><surname>Hasegawa</surname><given-names>Y.</given-names></name><name><surname>Takane</surname><given-names>K.</given-names></name><name><surname>Koibuchi</surname><given-names>N.</given-names></name><name><surname>Cao</surname><given-names>C.</given-names></name><name><surname>Kim-Mitsuyama</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>High-fat-diet intake enhances cerebral amyloid angiopathy and cognitive impairment in a mouse model of Alzheimer’s disease, independently of metabolic disorders</article-title>. <source/>J. Am. Heart Assoc.
<volume>5</volume>:<fpage>e003154</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.115.003154</pub-id><pub-id pub-id-type="pmid">27412896</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Du</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Xiong</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Sodium butyrate exerts protective effect against Parkinson’s disease in mice via stimulation of glucagon like peptide-1</article-title>. <source/>J. Neurol. Sci.
<volume>381</volume>, <fpage>176</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2017.08.3235</pub-id><pub-id pub-id-type="pmid">28991675</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llorens</surname><given-names>F.</given-names></name><name><surname>Thüne</surname><given-names>K.</given-names></name><name><surname>Andrés-Benito</surname><given-names>P.</given-names></name><name><surname>Tahir</surname><given-names>W.</given-names></name><name><surname>Ansoleaga</surname><given-names>B.</given-names></name><name><surname>Hernández-Ortega</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>MicroRNA expression in the locus coeruleus, entorhinal cortex, and hippocampus at early and middle stages of braak neurofibrillary tangle pathology</article-title>. <source/>J. Mol. Neurosci.
<volume>63</volume>, <fpage>206</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-017-0971-4</pub-id><pub-id pub-id-type="pmid">28871468</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luong</surname><given-names>K. V. Q.</given-names></name><name><surname>Nguyen</surname><given-names>L. T. H.</given-names></name></person-group> (<year>2013</year>). <article-title>The beneficial role of thiamine in parkinson disease</article-title>. <source/>CNS Neurosci. Ther.
<volume>19</volume>, <fpage>461</fpage>–<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12078</pub-id><pub-id pub-id-type="pmid">23462281</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martignoni</surname><given-names>M.</given-names></name><name><surname>Groothuis</surname><given-names>G. M. M.</given-names></name><name><surname>de Kanter</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction</article-title>. <source/>Expert Opin. Drug Metab. Toxicol.
<volume>2</volume>, <fpage>875</fpage>–<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1517/17425255.2.6.875</pub-id><pub-id pub-id-type="pmid">17125407</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>S. B.</given-names></name><name><surname>Dowling</surname><given-names>A. L. S.</given-names></name><name><surname>Head</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Therapeutic interventions targeting β amyloid pathogenesis in an aging dog model</article-title>. <source/>Curr. Neuropharmacol.
<volume>9</volume>, <fpage>651</fpage>–<lpage>661</lpage>. <pub-id pub-id-type="doi">10.2174/157015911798376217</pub-id><pub-id pub-id-type="pmid">22654723</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitew</surname><given-names>S.</given-names></name><name><surname>Kirkcaldie</surname><given-names>M. T. K.</given-names></name><name><surname>Dickson</surname><given-names>T. C.</given-names></name><name><surname>Vickers</surname><given-names>J. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Altered synapses and gliotransmission in Alzheimer’s disease and AD model mice</article-title>. <source/>Neurobiol. Aging
<volume>34</volume>, <fpage>2341</fpage>–<lpage>2351</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2013.04.010</pub-id><pub-id pub-id-type="pmid">23643146</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mochel</surname><given-names>J. P.</given-names></name><name><surname>Jergens</surname><given-names>A. E.</given-names></name><name><surname>Kingsbury</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Martín</surname><given-names>M. G.</given-names></name><name><surname>Allenspach</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Intestinal stem cells to advance drug development, precision, and regenerative medicine: a paradigm shift in translational research</article-title>. <source/>AAPS J.
<volume>20</volume>:<fpage>17</fpage>. <pub-id pub-id-type="doi">10.1208/s12248-017-0178-1</pub-id><pub-id pub-id-type="pmid">29234895</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogi</surname><given-names>M.</given-names></name><name><surname>Harada</surname><given-names>M.</given-names></name><name><surname>Narabayashi</surname><given-names>H.</given-names></name><name><surname>Inagaki</surname><given-names>H.</given-names></name><name><surname>Minami</surname><given-names>M.</given-names></name><name><surname>Nagatsu</surname><given-names>T.</given-names></name></person-group> (<year>1996</year>). <article-title>Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile Parkinsonism and Parkinson’s disease</article-title>. <source/>Neurosci. Lett.
<volume>211</volume>, <fpage>13</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(96)12706-3</pub-id><pub-id pub-id-type="pmid">8809836</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moloney</surname><given-names>R. D.</given-names></name><name><surname>Desbonnet</surname><given-names>L.</given-names></name><name><surname>Clarke</surname><given-names>G.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name></person-group> (<year>2014</year>). <article-title>The microbiome: stress, health and disease</article-title>. <source/>Mamm. Genome
<volume>25</volume>, <fpage>49</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-013-9488-5</pub-id><pub-id pub-id-type="pmid">24281320</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monsell</surname><given-names>S. E.</given-names></name><name><surname>Kukull</surname><given-names>W. A.</given-names></name><name><surname>Roher</surname><given-names>A. E.</given-names></name><name><surname>Maarouf</surname><given-names>C. L.</given-names></name><name><surname>Serrano</surname><given-names>G.</given-names></name><name><surname>Beach</surname><given-names>T. G.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Characterizing apolipoprotein E ɛ4 carriers and noncarriers with the clinical diagnosis of mild to moderate Alzheimer dementia and minimal β-amyloid peptide plaques</article-title>. <source/>JAMA Neurol.
<volume>72</volume>, <fpage>1124</fpage>–<lpage>1131</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2015.1721</pub-id><pub-id pub-id-type="pmid">26302353</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>D. L.</given-names></name><name><surname>Storts</surname><given-names>R. W.</given-names></name></person-group> (<year>1983</year>). <article-title>Hereditary striatonigral and cerebello-olivary degeneration of the kerry blue terrier. I. Gross and light microscopic central nervous system lesions</article-title>. <source/>Vet. Pathol.
<volume>20</volume>, <fpage>143</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1177/030098588302000202</pub-id><pub-id pub-id-type="pmid">6836871</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>R.</given-names></name><name><surname>Moreno-Gonzalez</surname><given-names>I.</given-names></name><name><surname>Soto</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases</article-title>. <source/>PLoS Pathog.
<volume>9</volume>:<fpage>e1003537</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003537</pub-id><pub-id pub-id-type="pmid">24068917</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muegge</surname><given-names>B. D.</given-names></name><name><surname>Kuczynski</surname><given-names>J.</given-names></name><name><surname>Knights</surname><given-names>D.</given-names></name><name><surname>Clemente</surname><given-names>J. C.</given-names></name><name><surname>González</surname><given-names>A.</given-names></name><name><surname>Fontana</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans</article-title>. <source/>Science
<volume>332</volume>, <fpage>970</fpage>–<lpage>974</lpage>. <pub-id pub-id-type="doi">10.1126/science.1198719</pub-id><pub-id pub-id-type="pmid">21596990</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>K. N.</given-names></name><name><surname>Mounier</surname><given-names>A.</given-names></name><name><surname>Wolfe</surname><given-names>C. M.</given-names></name><name><surname>Fitz</surname><given-names>N. F.</given-names></name><name><surname>Carter</surname><given-names>A. Y.</given-names></name><name><surname>Castranio</surname><given-names>E. L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Effect of high fat diet on phenotype, brain transcriptome and lipidome in Alzheimer’s model mice</article-title>. <source/>Sci. Rep.
<volume>7</volume>:<fpage>4307</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-04412-2</pub-id><pub-id pub-id-type="pmid">28655926</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>D. P.</given-names></name><name><surname>Johnson</surname><given-names>G. S.</given-names></name><name><surname>Schnabel</surname><given-names>R. D.</given-names></name><name><surname>Khan</surname><given-names>S.</given-names></name><name><surname>Coates</surname><given-names>J. R.</given-names></name><name><surname>Johnson</surname><given-names>G. C.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Genetic mapping of canine multiple system degeneration and ectodermal dysplasia loci</article-title>. <source/>J. Hered.
<volume>96</volume>, <fpage>727</fpage>–<lpage>734</lpage>. <pub-id pub-id-type="doi">10.1093/jhered/esi086</pub-id><pub-id pub-id-type="pmid">15958791</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Mahony</surname><given-names>S. M.</given-names></name><name><surname>Hyland</surname><given-names>N. P.</given-names></name><name><surname>Dinan</surname><given-names>T. G.</given-names></name><name><surname>Cryan</surname><given-names>J. F.</given-names></name></person-group> (<year>2011</year>). <article-title>Maternal separation as a model of brain-gut axis dysfunction</article-title>. <source/>Psychopharmacology
<volume>214</volume>, <fpage>71</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-010-2010-9</pub-id><pub-id pub-id-type="pmid">20886335</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oli</surname><given-names>M. W.</given-names></name><name><surname>Otoo</surname><given-names>H. N.</given-names></name><name><surname>Crowley</surname><given-names>P. J.</given-names></name><name><surname>Heim</surname><given-names>K. P.</given-names></name><name><surname>Nascimento</surname><given-names>M. M.</given-names></name><name><surname>Ramsook</surname><given-names>C. B.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Functional amyloid formation by streptococcus mutans</article-title>. <source/>Microbiology
<volume>158</volume>, <fpage>2903</fpage>–<lpage>2916</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.060855-0</pub-id><pub-id pub-id-type="pmid">23082034</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>H.</given-names></name><name><surname>Betton</surname><given-names>G.</given-names></name><name><surname>Robinson</surname><given-names>D.</given-names></name><name><surname>Thomas</surname><given-names>K.</given-names></name><name><surname>Monro</surname><given-names>A.</given-names></name><name><surname>Kolaja</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Concordance of the toxicity of pharmaceuticals in humans and in animals</article-title>. <source/>Regul. Toxicol. Pharmacol.
<volume>32</volume>, <fpage>56</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1006/rtph.2000.1399</pub-id><pub-id pub-id-type="pmid">11029269</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>A.</given-names></name><name><surname>Malinovska</surname><given-names>L.</given-names></name><name><surname>Saha</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Alberti</surname><given-names>S.</given-names></name><name><surname>Krishnan</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>ATP as a biological hydrotrope</article-title>. <source/>Science
<volume>356</volume>, <fpage>753</fpage>–<lpage>756</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf6846</pub-id><pub-id pub-id-type="pmid">28522535</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patronek</surname><given-names>G. J.</given-names></name><name><surname>Waters</surname><given-names>D. J.</given-names></name><name><surname>Glickman</surname><given-names>L. T.</given-names></name></person-group> (<year>1997</year>). <article-title>Comparative longevity of pet dogs and humans: implications for gerontology research</article-title>. <source/>J. Gerontol. A Biol. Sci. Med. Sci.
<volume>52</volume>, <fpage>B171</fpage>–<lpage>B178</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/52a.3.b171</pub-id><pub-id pub-id-type="pmid">9158552</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paula-Lima</surname><given-names>A. C.</given-names></name><name><surname>Brito-Moreira</surname><given-names>J.</given-names></name><name><surname>Ferreira</surname><given-names>S. T.</given-names></name></person-group> (<year>2013</year>). <article-title>Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer’s disease</article-title>. <source/>J. Neurochem.
<volume>126</volume>, <fpage>191</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.12304</pub-id><pub-id pub-id-type="pmid">23668663</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perlman</surname><given-names>R. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Mouse models of human disease</article-title>. <source/>Evol. Med. Public Health
<volume>2016</volume>, <fpage>170</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1093/emph/eow014</pub-id><pub-id pub-id-type="pmid">27121451</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pistollato</surname><given-names>F.</given-names></name><name><surname>Cano</surname><given-names>S. S.</given-names></name><name><surname>Elio</surname><given-names>I.</given-names></name><name><surname>Vergara</surname><given-names>M. M.</given-names></name><name><surname>Giampieri</surname><given-names>F.</given-names></name><name><surname>Battino</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease</article-title>. <source/>Nutr. Rev.
<volume>74</volume>, <fpage>624</fpage>–<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1093/nutrit/nuw023</pub-id><pub-id pub-id-type="pmid">27634977</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prigione</surname><given-names>A.</given-names></name><name><surname>Isaias</surname><given-names>I. U.</given-names></name><name><surname>Galbussera</surname><given-names>A.</given-names></name><name><surname>Brighina</surname><given-names>L.</given-names></name><name><surname>Begni</surname><given-names>B.</given-names></name><name><surname>Andreoni</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Increased oxidative stress in lymphocytes from untreated Parkinson’s disease patients</article-title>. <source/>Parkinsonism Relat. Disord.
<volume>15</volume>, <fpage>327</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2008.05.013</pub-id><pub-id pub-id-type="pmid">18640066</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pugliese</surname><given-names>M.</given-names></name><name><surname>Carrasco</surname><given-names>J. L.</given-names></name><name><surname>Gomez-Anson</surname><given-names>B.</given-names></name><name><surname>Andrade</surname><given-names>C.</given-names></name><name><surname>Zamora</surname><given-names>A.</given-names></name><name><surname>Rodríguez</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Magnetic resonance imaging of cerebral involutional changes in dogs as markers of aging: an innovative tool adapted from a human visual rating scale</article-title>. <source/>Vet. J.
<volume>186</volume>, <fpage>166</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/j.tvjl.2009.08.009</pub-id><pub-id pub-id-type="pmid">19748805</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravussin</surname><given-names>Y.</given-names></name><name><surname>Koren</surname><given-names>O.</given-names></name><name><surname>Spor</surname><given-names>A.</given-names></name><name><surname>LeDuc</surname><given-names>C.</given-names></name><name><surname>Gutman</surname><given-names>R.</given-names></name><name><surname>Stombaugh</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Responses of gut microbiota to diet composition and weight loss in lean and obese mice</article-title>. <source/>Obesity Silver Spring
<volume>20</volume>, <fpage>738</fpage>–<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2011.111</pub-id><pub-id pub-id-type="pmid">21593810</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>S. H.</given-names></name><name><surname>Pothoulakis</surname><given-names>C.</given-names></name><name><surname>Mayer</surname><given-names>E. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Principles and clinical implications of the brain-gut-enteric microbiota axis</article-title>. <source/>Nat. Rev. Gastroenterol. Hepatol.
<volume>6</volume>, <fpage>306</fpage>–<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2009.35</pub-id><pub-id pub-id-type="pmid">19404271</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>N. P.</given-names></name><name><surname>de Miranda</surname><given-names>A. S.</given-names></name><name><surname>Teixeira</surname><given-names>A. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Insights into neuroinflammation in Parkinson’s disease: from biomarkers to anti-inflammatory based therapies</article-title>. <source/>Biomed Res. Int.
<volume>2015</volume>:<fpage>628192</fpage>. <pub-id pub-id-type="doi">10.1155/2015/628192</pub-id><pub-id pub-id-type="pmid">26295044</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rofina</surname><given-names>J. E.</given-names></name><name><surname>van Ederen</surname><given-names>A. M.</given-names></name><name><surname>Toussaint</surname><given-names>M. J. M.</given-names></name><name><surname>Secrève</surname><given-names>M.</given-names></name><name><surname>van der Spek</surname><given-names>A.</given-names></name><name><surname>van der Meer</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer’s disease</article-title>. <source/>Brain Res.
<volume>1069</volume>, <fpage>216</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2005.11.021</pub-id><pub-id pub-id-type="pmid">16423332</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenfeld</surname><given-names>C. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Microbiome disturbances and autism spectrum disorders</article-title>. <source/>Drug Metab. Dispos.
<volume>43</volume>, <fpage>1557</fpage>–<lpage>1571</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.115.063826</pub-id><pub-id pub-id-type="pmid">25852213</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>G.</given-names></name><name><surname>Dicke</surname><given-names>U.</given-names></name></person-group> (<year>2005</year>). <article-title>Evolution of the brain and intelligence</article-title>. <source/>Trends Cogn. Sci.
<volume>9</volume>, <fpage>250</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1016/j.tics.2005.03.005</pub-id><pub-id pub-id-type="pmid">15866152</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>L. L.</given-names></name><name><surname>Hall</surname><given-names>D. E.</given-names></name><name><surname>Porter</surname><given-names>S.</given-names></name><name><surname>Barbu</surname><given-names>K.</given-names></name><name><surname>Cannon</surname><given-names>C.</given-names></name><name><surname>Horner</surname><given-names>H. C.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>A cell culture model of the blood-brain barrier</article-title>. <source/>J. Cell Biol.
<volume>115</volume>, <fpage>1725</fpage>–<lpage>1735</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.115.6.1725</pub-id><pub-id pub-id-type="pmid">1661734</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakakibara</surname><given-names>R.</given-names></name><name><surname>Odaka</surname><given-names>T.</given-names></name><name><surname>Uchiyama</surname><given-names>T.</given-names></name><name><surname>Asahina</surname><given-names>M.</given-names></name><name><surname>Yamaguchi</surname><given-names>K.</given-names></name><name><surname>Yamaguchi</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Colonic transit time and rectoanal videomanometry in Parkinson’s disease</article-title>. <source/>J. Neurol. Neurosurg. Psychiatry
<volume>74</volume>, <fpage>268</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.74.2.268</pub-id><pub-id pub-id-type="pmid">12531969</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampson</surname><given-names>T. R.</given-names></name><name><surname>Debelius</surname><given-names>J. W.</given-names></name><name><surname>Thron</surname><given-names>T.</given-names></name><name><surname>Janssen</surname><given-names>S.</given-names></name><name><surname>Shastri</surname><given-names>G. G.</given-names></name><name><surname>Ilhan</surname><given-names>Z. E.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Gut Microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease</article-title>. <source/>Cell
<volume>167</volume>, <fpage>1469.e12</fpage>–<lpage>1480.e12</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.11.018</pub-id><pub-id pub-id-type="pmid">27912057</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santaguida</surname><given-names>S.</given-names></name><name><surname>Janigro</surname><given-names>D.</given-names></name><name><surname>Hossain</surname><given-names>M.</given-names></name><name><surname>Oby</surname><given-names>E.</given-names></name><name><surname>Rapp</surname><given-names>E.</given-names></name><name><surname>Cucullo</surname><given-names>L.</given-names></name></person-group> (<year>2006</year>). <article-title>Side by side comparison between dynamic versus static models of blood-brain barrier <italic>in vitro</italic>: a permeability study</article-title>. <source/>Brain Res.
<volume>1109</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2006.06.027</pub-id><pub-id pub-id-type="pmid">16857178</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Clevers</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications</article-title>. <source/>Science
<volume>340</volume>, <fpage>1190</fpage>–<lpage>1194</lpage>. <pub-id pub-id-type="doi">10.1126/science.1234852</pub-id><pub-id pub-id-type="pmid">23744940</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saulnier</surname><given-names>D. M.</given-names></name><name><surname>Ringel</surname><given-names>Y.</given-names></name><name><surname>Heyman</surname><given-names>M. B.</given-names></name><name><surname>Foster</surname><given-names>J. A.</given-names></name><name><surname>Bercik</surname><given-names>P.</given-names></name><name><surname>Shulman</surname><given-names>R. J.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The intestinal microbiome, probiotics and prebiotics in neurogastroenterology</article-title>. <source/>Gut Microbes
<volume>4</volume>, <fpage>17</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.4161/gmic.22973</pub-id><pub-id pub-id-type="pmid">23202796</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheperjans</surname><given-names>F.</given-names></name><name><surname>Aho</surname><given-names>V.</given-names></name><name><surname>Pereira</surname><given-names>P. A. B.</given-names></name><name><surname>Koskinen</surname><given-names>K.</given-names></name><name><surname>Paulin</surname><given-names>L.</given-names></name><name><surname>Pekkonen</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Gut microbiota are related to Parkinson’s disease and clinical phenotype</article-title>. <source/>Mov. Disord.
<volume>30</volume>, <fpage>350</fpage>–<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26069</pub-id><pub-id pub-id-type="pmid">25476529</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schütt</surname><given-names>T.</given-names></name><name><surname>Helboe</surname><given-names>L.</given-names></name><name><surname>Pedersen</surname><given-names>L. Ø.</given-names></name><name><surname>Waldemar</surname><given-names>G.</given-names></name><name><surname>Berendt</surname><given-names>M.</given-names></name><name><surname>Pedersen</surname><given-names>J. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Dogs with cognitive dysfunction as a spontaneous model for early Alzheimer’s disease: a translational study of neuropathological and inflammatory markers</article-title>. <source/>J. Alzheimers Dis.
<volume>52</volume>, <fpage>433</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-151085</pub-id><pub-id pub-id-type="pmid">27003213</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schütt</surname><given-names>T.</given-names></name><name><surname>Toft</surname><given-names>N.</given-names></name><name><surname>Berendt</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Cognitive function, progression of age-related behavioral changes, biomarkers, and survival in dogs more than 8 years old</article-title>. <source/>J. Vet. Intern. Med.
<volume>29</volume>, <fpage>1569</fpage>–<lpage>1577</lpage>. <pub-id pub-id-type="doi">10.1111/jvim.13633</pub-id><pub-id pub-id-type="pmid">26463980</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>K.</given-names></name><name><surname>Boles</surname><given-names>B. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Microbial amyloids—functions and interactions within the host</article-title>. <source/>Curr. Opin. Microbiol.
<volume>16</volume>, <fpage>93</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2012.12.001</pub-id><pub-id pub-id-type="pmid">23313395</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwiertz</surname><given-names>A.</given-names></name><name><surname>Spiegel</surname><given-names>J.</given-names></name><name><surname>Dillmann</surname><given-names>U.</given-names></name><name><surname>Grundmann</surname><given-names>D.</given-names></name><name><surname>Bürmann</surname><given-names>J.</given-names></name><name><surname>Faßbender</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson’s disease</article-title>. <source/>Parkinsonism Relat. Disord.
<volume>50</volume>, <fpage>104</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2018.02.022</pub-id><pub-id pub-id-type="pmid">29454662</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>K. M.</given-names></name><name><surname>Keshavarzian</surname><given-names>A.</given-names></name><name><surname>Mutlu</surname><given-names>E.</given-names></name><name><surname>Dodiya</surname><given-names>H. B.</given-names></name><name><surname>Daian</surname><given-names>D.</given-names></name><name><surname>Jaglin</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>α-synuclein in colonic submucosa in early untreated Parkinson’s disease</article-title>. <source/>Mov. Disord.
<volume>27</volume>, <fpage>709</fpage>–<lpage>715</lpage>. <pub-id pub-id-type="doi">10.1002/mds.23838</pub-id><pub-id pub-id-type="pmid">21766334</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>T. D.</given-names></name><name><surname>Zeleznikow-Johnston</surname><given-names>A. M.</given-names></name><name><surname>Hannan</surname><given-names>A. J.</given-names></name><name><surname>Burrows</surname><given-names>E. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Transgenic mouse models as tools for understanding how increased cognitive and physical stimulation can improve cognition in Alzheimer’s disease</article-title>. <source/>Brain Plast.
<volume>4</volume>, <fpage>127</fpage>–<lpage>150</lpage>. <pub-id pub-id-type="doi">10.3233/bpl-180076</pub-id><pub-id pub-id-type="pmid">30564551</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>A.</given-names></name><name><surname>Massidda</surname><given-names>M. W.</given-names></name><name><surname>Foster</surname><given-names>C.</given-names></name><name><surname>Thomas</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>D.-W.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>A robust longitudinal co-culture of obligate anaerobic gut microbiome with human intestinal epithelium in an anoxic-oxic interface-on-a-chip</article-title>. <source/>Front. Bioeng. Biotechnol.
<volume>7</volume>:<fpage>13</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2019.00013</pub-id><pub-id pub-id-type="pmid">30792981</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>115</volume>, <fpage>E10539</fpage>–<lpage>E10547</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1810819115</pub-id><pub-id pub-id-type="pmid">30348765</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smolek</surname><given-names>T.</given-names></name><name><surname>Madari</surname><given-names>A.</given-names></name><name><surname>Farbakova</surname><given-names>J.</given-names></name><name><surname>Kandrac</surname><given-names>O.</given-names></name><name><surname>Jadhav</surname><given-names>S.</given-names></name><name><surname>Cente</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment</article-title>. <source/>J. Comp. Neurol.
<volume>524</volume>, <fpage>874</fpage>–<lpage>895</lpage>. <pub-id pub-id-type="doi">10.1002/cne.23877</pub-id><pub-id pub-id-type="pmid">26239295</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokoloff</surname><given-names>L.</given-names></name></person-group> (<year>1973</year>). <article-title>Metabolism of ketone bodies by the brain</article-title>. <source/>Annu. Rev. Med.
<volume>24</volume>, <fpage>271</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.me.24.020173.001415</pub-id><pub-id pub-id-type="pmid">4575857</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanko</surname><given-names>D. P.</given-names></name><name><surname>Barrett</surname><given-names>R. M.</given-names></name><name><surname>Ly</surname><given-names>A. R.</given-names></name><name><surname>Reolon</surname><given-names>G. K.</given-names></name><name><surname>Wood</surname><given-names>M. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Modulation of long-term memory for object recognition via HDAC inhibition</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>106</volume>, <fpage>9447</fpage>–<lpage>9452</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0903964106</pub-id><pub-id pub-id-type="pmid">19470462</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>T.</given-names></name><name><surname>Hevner</surname><given-names>R. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Growth and folding of the mammalian cerebral cortex: from molecules to malformations</article-title>. <source/>Nat. Rev. Neurosci.
<volume>15</volume>, <fpage>217</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3707</pub-id><pub-id pub-id-type="pmid">24646670</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>M.-Y.</given-names></name><name><surname>Tapp</surname><given-names>P. D.</given-names></name><name><surname>Vu</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Y.-F.</given-names></name><name><surname>Chu</surname><given-names>Y.</given-names></name><name><surname>Muggenburg</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>A longitudinal study of brain morphometrics using serial magnetic resonance imaging analysis in a canine model of aging</article-title>. <source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
<volume>29</volume>, <fpage>389</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2004.12.005</pub-id><pub-id pub-id-type="pmid">15795047</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>J. H.</given-names></name><name><surname>Shuler</surname><given-names>M. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Prevention of air bubble formation in a microfluidic perfusion cell culture system using a microscale bubble trap</article-title>. <source/>Biomed. Microdevices
<volume>11</volume>, <fpage>731</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1007/s10544-009-9286-8</pub-id><pub-id pub-id-type="pmid">19212816</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>J. H.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>D.</given-names></name><name><surname>Shuler</surname><given-names>M. L.</given-names></name><name><surname>March</surname><given-names>J. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Microscale 3-D hydrogel scaffold for biomimetic gastrointestinal (GI) tract model</article-title>. <source/>Lab Chip
<volume>11</volume>, <fpage>389</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1039/c0lc00273a</pub-id><pub-id pub-id-type="pmid">21157619</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>A. H.</given-names></name><name><surname>Mahadeva</surname><given-names>S.</given-names></name><name><surname>Thalha</surname><given-names>A. M.</given-names></name><name><surname>Gibson</surname><given-names>P. R.</given-names></name><name><surname>Kiew</surname><given-names>C. K.</given-names></name><name><surname>Yeat</surname><given-names>C. M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Small intestinal bacterial overgrowth in Parkinson’s disease</article-title>. <source/>Parkinsonism Relat. Disord.
<volume>20</volume>, <fpage>535</fpage>–<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2014.02.019</pub-id><pub-id pub-id-type="pmid">24637123</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terao</surname><given-names>M.</given-names></name><name><surname>Kurosaki</surname><given-names>M.</given-names></name><name><surname>Barzago</surname><given-names>M. M.</given-names></name><name><surname>Varasano</surname><given-names>E.</given-names></name><name><surname>Boldetti</surname><given-names>A.</given-names></name><name><surname>Bastone</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Avian and canine aldehyde oxidases. Novel insights into the biology and evolution of molybdo-flavoenzymes</article-title>. <source/>J. Biol. Chem.
<volume>281</volume>, <fpage>19748</fpage>–<lpage>19761</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m600850200</pub-id><pub-id pub-id-type="pmid">16672219</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tilg</surname><given-names>H.</given-names></name><name><surname>Moschen</surname><given-names>A. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Microbiota and diabetes: an evolving relationship</article-title>. <source/>Gut
<volume>63</volume>, <fpage>1513</fpage>–<lpage>1521</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2014-306928</pub-id><pub-id pub-id-type="pmid">24833634</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsigos</surname><given-names>C.</given-names></name><name><surname>Chrousos</surname><given-names>G. P.</given-names></name></person-group> (<year>2002</year>). <article-title>Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress</article-title>. <source/>J. Psychosom. Res.
<volume>53</volume>, <fpage>865</fpage>–<lpage>871</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3999(02)00429-4</pub-id><pub-id pub-id-type="pmid">12377295</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vangay</surname><given-names>P.</given-names></name><name><surname>Ward</surname><given-names>T.</given-names></name><name><surname>Gerber</surname><given-names>J. S.</given-names></name><name><surname>Knights</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Antibiotics, pediatric dysbiosis, and disease</article-title>. <source/>Cell Host Microbe
<volume>17</volume>, <fpage>553</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2015.04.006</pub-id><pub-id pub-id-type="pmid">25974298</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vecsey</surname><given-names>C. G.</given-names></name><name><surname>Hawk</surname><given-names>J. D.</given-names></name><name><surname>Lattal</surname><given-names>K. M.</given-names></name><name><surname>Stein</surname><given-names>J. M.</given-names></name><name><surname>Fabian</surname><given-names>S. A.</given-names></name><name><surname>Attner</surname><given-names>M. A.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Histone deacetylase inhibitors enhance memory and synaptic plasticity <italic>via</italic> CREB: CBP-dependent transcriptional activation</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>6128</fpage>–<lpage>6140</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0296-07.2007</pub-id><pub-id pub-id-type="pmid">17553985</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y. I.</given-names></name><name><surname>Abaci</surname><given-names>H. E.</given-names></name><name><surname>Shuler</surname><given-names>M. L.</given-names></name></person-group> (<year>2017</year>). <article-title>Microfluidic blood-brain barrier model provides <italic>in vivo</italic>-like barrier properties for drug permeability screening</article-title>. <source/>Biotechnol. Bioeng.
<volume>114</volume>, <fpage>184</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1002/bit.26045</pub-id><pub-id pub-id-type="pmid">27399645</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>Y. C.</given-names></name><name><surname>Krainc</surname><given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies</article-title>. <source/>Nat. Med.
<volume>23</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/nm.4269</pub-id><pub-id pub-id-type="pmid">28170377</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Kisseberth</surname><given-names>W. C.</given-names></name><name><surname>Henry</surname><given-names>C. J.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Proliferative and invasive colorectal tumors in pet dogs provide unique insights into human colorectal cancer</article-title>. <source/>Cancers
<volume>10</volume>:<fpage>E330</fpage>. <pub-id pub-id-type="doi">10.3390/cancers10090330</pub-id><pub-id pub-id-type="pmid">30223484</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.-C.</given-names></name><name><surname>Cao</surname><given-names>Z.-S.</given-names></name><name><surname>Chang</surname><given-names>K.-M.</given-names></name><name><surname>Juang</surname><given-names>J.-L.</given-names></name></person-group> (<year>2017</year>). <article-title>Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in <italic>Drosophila</italic></article-title>. <source/>Nat. Commun.
<volume>8</volume>:<fpage>24</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-00040-6</pub-id><pub-id pub-id-type="pmid">28634323</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshioka</surname><given-names>H.</given-names></name><name><surname>Takeda</surname><given-names>T.</given-names></name><name><surname>Higuchi</surname><given-names>K.</given-names></name><name><surname>Ohshio</surname><given-names>G.</given-names></name><name><surname>Miyake</surname><given-names>T.</given-names></name><name><surname>Sugiyama</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>1990</year>). <article-title>Immunohistochemical examination of Peyer’s patches in senescence-accelerated mice</article-title>. <source/>Autoimmunity
<volume>8</volume>, <fpage>25</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.3109/08916939008998429</pub-id><pub-id pub-id-type="pmid">2129782</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>C.-H.</given-names></name><name><surname>Song</surname><given-names>G.-S.</given-names></name><name><surname>Yhee</surname><given-names>J.-Y.</given-names></name><name><surname>Kim</surname><given-names>J.-H.</given-names></name><name><surname>Im</surname><given-names>K.-S.</given-names></name><name><surname>Nho</surname><given-names>W.-G.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer’s disease and the brain of aged dogs with cognitive dysfunction</article-title>. <source/>J. Comp. Pathol.
<volume>145</volume>, <fpage>45</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcpa.2010.11.004</pub-id><pub-id pub-id-type="pmid">21256508</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Fitzloff</surname><given-names>J. F.</given-names></name><name><surname>Engel</surname><given-names>L. C.</given-names></name><name><surname>Cook</surname><given-names>C. S.</given-names></name></person-group> (<year>2001</year>). <article-title>Species difference in stereoselective involvement of CYP3A in the mono-N-dealkylation of disopyramide</article-title>. <source/>Xenobiotica
<volume>31</volume>, <fpage>73</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1080/00498250110037488</pub-id><pub-id pub-id-type="pmid">11407536</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Hou</surname><given-names>D.</given-names></name><name><surname>Deng</surname><given-names>H.</given-names></name><name><surname>Deng</surname><given-names>Y. L.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Comparative epidemiological investigation of Alzheimer’s disease and colorectal cancer: the possible role of gastrointestinal conditions in the pathogenesis of AD</article-title>. <source/>Front. Aging Neurosci.
<volume>10</volume>:<fpage>176</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2018.00176</pub-id><pub-id pub-id-type="pmid">30323761</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>S.-P.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Smith</surname><given-names>D. E.</given-names></name><name><surname>Wiley</surname><given-names>J. W.</given-names></name><name><surname>Hong</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Corticosterone mediates stress-related increased intestinal permeability in a region-specific manner</article-title>. <source/>Neurogastroenterol. Motil.
<volume>25</volume>, <fpage>e127</fpage>–<lpage>e139</lpage>. <pub-id pub-id-type="doi">10.1111/nmo.12066</pub-id><pub-id pub-id-type="pmid">23336591</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>